| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.889 | 0.001 | 0.889 | Glutamate decarboxylase inhibitor | 0.266 0.004 DBMET00637 0.234 0.005 DBMET00698 0.234 0.005 DBMET00699 0.252 0.004 DBMET00700 0.16 0.011 DBMET00701 0.16 0.011 DBMET00702 | ||
| 0.843 | 0.002 | 0.843 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.812 | 0.004 | 0.812 | Cardiotonic | 0.371 0.034 DBMET00698 0.238 0.091 DBMET00699 0.265 0.072 DBMET00700 0.371 0.034 DBMET00701 0.255 0.079 DBMET00702 | ||
| 0.764 | 0.002 | 0.764 | Tyrosine 3 hydroxylase inhibitor | 0.55 0.003 DBMET00637 0.714 0.002 DBMET00698 0.75 0.002 DBMET00699 0.75 0.002 DBMET00700 0.59 0.003 DBMET00701 0.631 0.003 DBMET00702 | ||
| 0.763 | 0.008 | 0.763 | 15-Lipoxygenase inhibitor | 0.452 0.053 DBMET00637 0.303 0.13 DBMET00699 0.327 0.113 DBMET00700 0.347 0.101 DBMET00702 | ||
| 0.692 | 0.004 | 0.692 | Dopamine agonist | |||
| 0.655 | 0.004 | 0.655 | Peroxidase inhibitor | 0.535 0.007 DBMET00637 0.528 0.008 DBMET00698 0.586 0.005 DBMET00699 0.591 0.005 DBMET00700 0.434 0.016 DBMET00701 0.5 0.01 DBMET00702 | ||
| 0.644 | 0.003 | 0.644 | Alcohol oxidase inhibitor | 0.183 0.007 DBMET00637 0.282 0.005 DBMET00698 0.282 0.005 DBMET00699 0.206 0.006 DBMET00700 0.098 0.019 DBMET00701 0.098 0.019 DBMET00702 | ||
| 0.621 | 0.001 | 0.621 | DOPA decarboxylase inhibitor | 0.315 0.002 DBMET00637 0.233 0.004 DBMET00698 0.273 0.003 DBMET00699 0.292 0.003 DBMET00700 0.199 0.007 DBMET00701 0.235 0.004 DBMET00702 | ||
| 0.613 | 0.017 | 0.742 | Aldehyde oxidase inhibitor | 0.719 0.007 DBMET00637 0.657 0.012 DBMET00698 0.736 0.006 DBMET00699 0.725 0.007 DBMET00700 0.663 0.011 DBMET00701 0.742 0.005 DBMET00702 | DBMET00702 | |
| 0.588 | 0.002 | 0.588 | Histidine decarboxylase inhibitor | 0.382 0.004 DBMET00637 0.296 0.006 DBMET00698 0.239 0.01 DBMET00699 0.252 0.009 DBMET00700 0.243 0.009 DBMET00701 0.193 0.014 DBMET00702 | ||
| 0.567 | 0.009 | 0.567 | Hypoxia-inducible factor 1 alpha inhibitor | 0.329 0.053 DBMET00637 0.191 0.162 DBMET00699 0.198 0.154 DBMET00700 0.213 0.137 DBMET00701 0.236 0.113 DBMET00702 | ||
| 0.53 | 0.015 | 0.53 | Lipoxygenase inhibitor | 0.384 0.041 DBMET00637 0.242 0.105 DBMET00698 0.352 0.05 DBMET00699 0.382 0.042 DBMET00700 0.297 0.072 DBMET00701 0.421 0.032 DBMET00702 | ||
| 0.438 | 0.006 | 0.438 | Lck kinase inhibitor | |||
| 0.42 | 0.004 | 0.42 | Cystathionine beta-synthase inhibitor | 0.312 0.009 DBMET00637 0.305 0.009 DBMET00698 0.335 0.007 DBMET00699 0.344 0.007 DBMET00700 0.283 0.011 DBMET00701 0.311 0.009 DBMET00702 | ||
| 0.463 | 0.05 | 0.539 | Transcription factor NF kappa B inhibitor | 0.455 0.052 DBMET00637 0.362 0.073 DBMET00698 0.468 0.049 DBMET00699 0.483 0.047 DBMET00700 0.433 0.056 DBMET00701 0.539 0.039 DBMET00702 | DBMET00702 | |
| 0.433 | 0.024 | 0.594 | Free radical scavenger | 0.594 0.009 DBMET00637 0.306 0.05 DBMET00698 0.348 0.039 DBMET00699 0.422 0.025 DBMET00700 0.396 0.029 DBMET00701 0.429 0.025 DBMET00702 | DBMET00637 | |
| 0.408 | 0.019 | 0.408 | Pyruvate kinase inhibitor | 0.306 0.046 DBMET00637 0.211 0.075 DBMET00698 0.19 0.087 DBMET00699 0.197 0.082 DBMET00700 0.225 0.069 DBMET00701 0.201 0.08 DBMET00702 | ||
| 0.422 | 0.049 | 0.525 | Vasodilator, peripheral | 0.461 0.037 DBMET00637 0.333 0.081 DBMET00698 0.459 0.038 DBMET00699 0.486 0.031 DBMET00700 0.408 0.053 DBMET00701 0.525 0.024 DBMET00702 | DBMET00702 | |
| 0.355 | 0.024 | 0.514 | 5 Hydroxytryptamine uptake stimulant | 0.514 0.004 DBMET00637 0.457 0.006 DBMET00698 0.451 0.007 DBMET00699 0.494 0.005 DBMET00700 0.489 0.005 DBMET00701 0.484 0.005 DBMET00702 | DBMET00637 | |
| 0.354 | 0.023 | 0.58 | Anesthetic general | 0.437 0.012 DBMET00637 0.569 0.005 DBMET00698 0.58 0.005 DBMET00699 0.565 0.005 DBMET00700 0.543 0.005 DBMET00701 0.554 0.005 DBMET00702 | DBMET00699 | |
| 0.383 | 0.053 | 0.663 | Cholesterol antagonist | 0.493 0.034 DBMET00637 0.663 0.011 DBMET00698 0.651 0.012 DBMET00699 0.656 0.012 DBMET00700 0.649 0.013 DBMET00701 0.637 0.014 DBMET00702 | DBMET00698 | |
| 0.355 | 0.035 | 0.587 | Superoxide dismutase inhibitor | 0.559 0.009 DBMET00637 0.39 0.028 DBMET00698 0.482 0.015 DBMET00699 0.512 0.012 DBMET00700 0.477 0.015 DBMET00701 0.587 0.007 DBMET00702 | DBMET00702 | |
| 0.321 | 0.003 | 0.321 | Maillard reaction inhibitor | 0.099 0.017 DBMET00698 0.056 0.037 DBMET00699 0.067 0.031 DBMET00700 0.088 0.021 DBMET00701 0.051 0.043 DBMET00702 | ||
| 0.343 | 0.033 | 0.343 | Psychostimulant | 0.195 0.083 DBMET00637 0.226 0.068 DBMET00698 0.299 0.043 DBMET00699 0.285 0.047 DBMET00700 0.19 0.086 DBMET00701 0.258 0.056 DBMET00702 | ||
| 0.346 | 0.047 | 0.55 | Antioxidant | 0.55 0.015 DBMET00637 0.408 0.034 DBMET00698 0.365 0.042 DBMET00699 0.435 0.029 DBMET00700 0.462 0.025 DBMET00701 0.43 0.03 DBMET00702 | DBMET00637 | |
| 0.296 | 0.018 | 0.541 | Monophenol monooxygenase inhibitor | 0.541 0.006 DBMET00637 0.321 0.016 DBMET00698 0.312 0.017 DBMET00699 0.318 0.016 DBMET00700 0.358 0.013 DBMET00701 0.346 0.014 DBMET00702 | DBMET00637 | |
| 0.319 | 0.063 | 0.394 | Sodium/bile acid cotransporter inhibitor | 0.315 0.066 DBMET00637 0.376 0.026 DBMET00698 0.394 0.019 DBMET00699 0.384 0.022 DBMET00700 0.358 0.035 DBMET00701 0.376 0.026 DBMET00702 | DBMET00699 | |
| 0.361 | 0.106 | 0.634 | 5 Hydroxytryptamine release inhibitor | 0.461 0.047 DBMET00637 0.494 0.034 DBMET00698 0.634 0.007 DBMET00699 0.59 0.012 DBMET00700 0.426 0.063 DBMET00701 0.57 0.015 DBMET00702 | DBMET00699 | |
| 0.251 | 0.004 | 0.305 | GABA aminotransferase inhibitor | 0.125 0.014 DBMET00637 0.196 0.004 DBMET00698 0.305 0.003 DBMET00699 0.268 0.004 DBMET00700 0.135 0.011 DBMET00701 0.175 0.005 DBMET00702 | DBMET00699 | |
| 0.268 | 0.039 | 0.268 | Growth hormone agonist | 0.134 0.102 DBMET00637 0.231 0.048 DBMET00698 0.261 0.041 DBMET00699 0.234 0.048 DBMET00700 0.157 0.082 DBMET00701 0.177 0.069 DBMET00702 | ||
| 0.346 | 0.125 | 0.78 | Cyclophilin D inhibitor | 0.78 0.008 DBMET00698 0.625 0.023 DBMET00699 0.66 0.018 DBMET00700 0.708 0.013 DBMET00701 0.54 0.04 DBMET00702 | DBMET00698 | |
| 0.253 | 0.035 | 0.253 | Src kinase inhibitor | |||
| 0.289 | 0.074 | 0.368 | Spasmolytic | 0.255 0.089 DBMET00637 0.263 0.086 DBMET00698 0.344 0.054 DBMET00699 0.351 0.052 DBMET00700 0.286 0.075 DBMET00701 0.368 0.047 DBMET00702 | DBMET00702 | |
| 0.322 | 0.112 | 0.593 | Histamine release inhibitor | 0.432 0.059 DBMET00637 0.593 0.011 DBMET00698 0.506 0.027 DBMET00699 0.517 0.024 DBMET00700 0.569 0.013 DBMET00701 0.489 0.033 DBMET00702 | DBMET00698 | |
| 0.235 | 0.028 | 0.52 | Succinate dehydrogenase inhibitor | 0.391 0.004 DBMET00637 0.285 0.013 DBMET00698 0.44 0.004 DBMET00699 0.52 0.003 DBMET00700 0.318 0.008 DBMET00701 0.513 0.003 DBMET00702 | DBMET00700 | |
| 0.208 | 0.004 | 0.208 | Ornithine decarboxylase inhibitor | 0.132 0.018 DBMET00637 0.115 0.03 DBMET00698 0.149 0.011 DBMET00699 0.16 0.009 DBMET00700 0.112 0.032 DBMET00701 0.145 0.013 DBMET00702 | ||
| 0.209 | 0.006 | 0.576 | Phenylalanine 4-hydroxylase inhibitor | 0.315 0.004 DBMET00637 0.576 0.002 DBMET00698 0.317 0.004 DBMET00699 0.346 0.004 DBMET00700 0.315 0.004 DBMET00701 0.146 0.013 DBMET00702 | DBMET00698 | |
| 0.238 | 0.046 | 0.447 | Neurotrophic factor enhancer | 0.442 0.005 DBMET00637 0.4 0.005 DBMET00698 0.432 0.005 DBMET00699 0.447 0.005 DBMET00700 0.382 0.007 DBMET00701 0.412 0.005 DBMET00702 | DBMET00700 | |
| 0.288 | 0.096 | 0.559 | Antithrombotic | 0.318 0.077 DBMET00637 0.316 0.079 DBMET00698 0.544 0.023 DBMET00699 0.559 0.021 DBMET00700 0.308 0.083 DBMET00701 0.537 0.024 DBMET00702 | DBMET00700 | |
| 0.239 | 0.048 | 0.307 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.307 0.021 DBMET00637 0.242 0.046 DBMET00698 0.255 0.04 DBMET00699 0.255 0.04 DBMET00700 0.248 0.044 DBMET00701 0.261 0.038 DBMET00702 | DBMET00637 | |
| 0.216 | 0.03 | 0.389 | Alpha-N-acetylglucosaminidase inhibitor | 0.345 0.012 DBMET00637 0.348 0.012 DBMET00698 0.348 0.012 DBMET00699 0.389 0.009 DBMET00700 0.204 0.033 DBMET00701 0.204 0.033 DBMET00702 | DBMET00700 | |
| 0.284 | 0.102 | 0.463 | Vasodilator, coronary | 0.306 0.083 DBMET00637 0.329 0.067 DBMET00698 0.389 0.039 DBMET00699 0.404 0.034 DBMET00700 0.394 0.037 DBMET00701 0.463 0.021 DBMET00702 | DBMET00702 | |
| 0.193 | 0.013 | 0.448 | Porphobilinogen synthase inhibitor | 0.448 0.004 DBMET00637 0.252 0.007 DBMET00698 0.252 0.007 DBMET00699 0.269 0.006 DBMET00700 0.096 0.038 DBMET00701 0.096 0.038 DBMET00702 | DBMET00637 | |
| 0.198 | 0.019 | 0.232 | Carbonic anhydrase XV inhibitor | 0.232 0.014 DBMET00637 0.122 0.045 DBMET00698 0.147 0.032 DBMET00699 0.152 0.03 DBMET00700 0.121 0.045 DBMET00701 0.146 0.032 DBMET00702 | DBMET00637 | |
| 0.192 | 0.014 | 0.194 | Carbonic anhydrase VI inhibitor | 0.194 0.014 DBMET00637 0.12 0.03 DBMET00698 0.155 0.02 DBMET00699 0.162 0.018 DBMET00700 0.124 0.028 DBMET00701 0.161 0.019 DBMET00702 | DBMET00637 | |
| 0.195 | 0.038 | 0.238 | Arachidonic acid antagonist | 0.238 0.009 DBMET00637 0.222 0.016 DBMET00698 0.23 0.012 DBMET00699 0.238 0.009 DBMET00700 0.217 0.019 DBMET00701 0.225 0.014 DBMET00702 | DBMET00700 | |
| 0.225 | 0.071 | 0.226 | Peptidyltransferase inhibitor | 0.204 0.094 DBMET00637 0.221 0.075 DBMET00698 0.213 0.083 DBMET00699 0.226 0.07 DBMET00700 0.21 0.087 DBMET00701 0.202 0.096 DBMET00702 | DBMET00700 | |
| 0.194 | 0.046 | 0.358 | Phospholipase A2 inhibitor | 0.251 0.023 DBMET00637 0.237 0.027 DBMET00698 0.358 0.007 DBMET00699 0.352 0.008 DBMET00700 0.203 0.041 DBMET00701 0.312 0.012 DBMET00702 | DBMET00699 | |
| 0.172 | 0.024 | 0.172 | Bronchodilator | 0.107 0.057 DBMET00637 0.113 0.05 DBMET00701 0.111 0.052 DBMET00702 | ||
| 0.175 | 0.03 | 0.242 | Adenylate cyclase stimulant | 0.215 0.008 DBMET00637 0.208 0.01 DBMET00698 0.225 0.006 DBMET00699 0.242 0.004 DBMET00700 0.203 0.012 DBMET00701 0.22 0.007 DBMET00702 | DBMET00700 | |
| 0.164 | 0.021 | 0.272 | HIV-1 integrase (Overall Integration) inhibitor | 0.242 0.005 DBMET00637 0.198 0.012 DBMET00698 0.241 0.005 DBMET00699 0.272 0.004 DBMET00700 0.17 0.019 DBMET00701 0.216 0.009 DBMET00702 | DBMET00700 | |
| 0.161 | 0.02 | 0.245 | Creatine kinase inhibitor | 0.245 0.006 DBMET00637 0.211 0.009 DBMET00698 0.211 0.009 DBMET00699 0.213 0.009 DBMET00700 0.119 0.041 DBMET00701 0.119 0.041 DBMET00702 | DBMET00637 | |
| 0.178 | 0.041 | 0.267 | M18 aspartyl aminopeptidase inhibitor | 0.267 0.017 DBMET00637 0.099 0.093 DBMET00698 0.098 0.094 DBMET00699 0.177 0.041 DBMET00700 0.156 0.049 DBMET00701 0.155 0.05 DBMET00702 | DBMET00637 | |
| 0.297 | 0.161 | 0.297 | Alpha-glucosidase inhibitor | |||
| 0.227 | 0.091 | 0.58 | Hypoglycemic | 0.17 0.148 DBMET00637 0.58 0.009 DBMET00698 0.409 0.026 DBMET00699 0.434 0.023 DBMET00700 0.54 0.012 DBMET00701 0.378 0.032 DBMET00702 | DBMET00698 | |
| 0.182 | 0.05 | 0.471 | Melanin inhibitor | 0.387 0.013 DBMET00637 0.369 0.014 DBMET00698 0.407 0.011 DBMET00699 0.418 0.011 DBMET00700 0.427 0.01 DBMET00701 0.471 0.008 DBMET00702 | DBMET00702 | |
| 0.16 | 0.031 | 0.212 | Xanthine oxidase inhibitor | 0.123 0.046 DBMET00637 0.113 0.051 DBMET00698 0.2 0.019 DBMET00699 0.212 0.017 DBMET00700 0.117 0.049 DBMET00701 0.204 0.019 DBMET00702 | DBMET00700 | |
| 0.218 | 0.091 | 0.402 | Vasodilator | 0.402 0.023 DBMET00637 0.185 0.118 DBMET00699 0.217 0.092 DBMET00700 0.163 0.139 DBMET00701 0.232 0.08 DBMET00702 | DBMET00637 | |
| 0.214 | 0.092 | 0.431 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.431 0.031 DBMET00637 0.167 0.123 DBMET00700 0.204 0.097 DBMET00702 | DBMET00637 | |
| 0.153 | 0.033 | 0.327 | GABA C receptor agonist | 0.236 0.015 DBMET00637 0.246 0.014 DBMET00698 0.287 0.01 DBMET00699 0.327 0.008 DBMET00700 0.126 0.046 DBMET00701 0.147 0.035 DBMET00702 | DBMET00700 | |
| 0.135 | 0.016 | 0.242 | HIV-1 integrase (3'-Processing) inhibitor | 0.242 0.007 DBMET00637 0.076 0.035 DBMET00698 0.083 0.032 DBMET00699 0.13 0.017 DBMET00700 0.107 0.024 DBMET00701 0.112 0.022 DBMET00702 | DBMET00637 | |
| 0.221 | 0.102 | 0.38 | Interleukin agonist | 0.298 0.049 DBMET00637 0.38 0.022 DBMET00698 0.349 0.029 DBMET00699 0.376 0.023 DBMET00700 0.361 0.026 DBMET00701 0.332 0.035 DBMET00702 | DBMET00698 | |
| 0.157 | 0.041 | 0.171 | Cathepsin H inhibitor | 0.149 0.047 DBMET00637 0.11 0.09 DBMET00698 0.171 0.033 DBMET00699 0.156 0.042 DBMET00700 0.12 0.075 DBMET00702 | DBMET00699 | |
| 0.141 | 0.027 | 0.141 | Nitric-oxide synthase inhibitor | 0.109 0.048 DBMET00637 | ||
| 0.164 | 0.051 | 0.164 | Alkaline phosphatase inhibitor | 0.147 0.061 DBMET00637 0.113 0.096 DBMET00699 0.128 0.077 DBMET00700 0.136 0.07 DBMET00702 | ||
| 0.136 | 0.025 | 0.192 | Carbonic anhydrase XIII inhibitor | 0.167 0.019 DBMET00637 0.143 0.023 DBMET00698 0.115 0.032 DBMET00699 0.125 0.028 DBMET00700 0.192 0.015 DBMET00701 0.154 0.021 DBMET00702 | DBMET00701 | |
| 0.22 | 0.109 | 0.345 | Immunostimulant | 0.278 0.086 DBMET00637 0.272 0.088 DBMET00698 0.345 0.066 DBMET00699 0.344 0.066 DBMET00700 0.212 0.113 DBMET00701 0.285 0.083 DBMET00702 | DBMET00699 | |
| 0.239 | 0.131 | 0.381 | Interleukin 2 agonist | 0.264 0.104 DBMET00637 0.318 0.062 DBMET00698 0.381 0.033 DBMET00699 0.373 0.036 DBMET00700 0.247 0.121 DBMET00701 0.313 0.065 DBMET00702 | DBMET00699 | |
| 0.172 | 0.066 | 0.396 | Thrombolytic | 0.138 0.092 DBMET00637 0.149 0.082 DBMET00698 0.372 0.014 DBMET00699 0.396 0.011 DBMET00700 0.141 0.089 DBMET00701 0.335 0.019 DBMET00702 | DBMET00700 | |
| 0.116 | 0.012 | 0.218 | Estrogen-related receptor beta agonist | 0.152 0.004 DBMET00637 0.151 0.004 DBMET00698 0.218 0.002 DBMET00699 0.185 0.003 DBMET00700 0.126 0.008 DBMET00701 0.174 0.003 DBMET00702 | DBMET00699 | |
| 0.155 | 0.053 | 0.229 | Sphingosine 1-phosphate receptor 5 antagonist | 0.186 0.019 DBMET00637 0.17 0.034 DBMET00698 0.219 0.006 DBMET00699 0.229 0.005 DBMET00700 0.146 0.069 DBMET00701 0.196 0.013 DBMET00702 | DBMET00700 | |
| 0.115 | 0.018 | 0.245 | HIV-1 integrase (Strand Transfer) inhibitor | 0.245 0.007 DBMET00637 0.067 0.037 DBMET00698 0.08 0.031 DBMET00699 0.118 0.017 DBMET00700 0.092 0.026 DBMET00701 0.102 0.022 DBMET00702 | DBMET00637 | |
| 0.194 | 0.099 | 0.297 | Nitric-oxide synthase stimulant | 0.297 0.012 DBMET00637 0.241 0.039 DBMET00698 0.274 0.02 DBMET00699 0.289 0.014 DBMET00700 0.254 0.03 DBMET00701 0.288 0.015 DBMET00702 | DBMET00637 | |
| 0.099 | 0.004 | 0.099 | Calcium-sensing receptor antagonist | |||
| 0.142 | 0.048 | 0.405 | Vanilloid 1 agonist | 0.209 0.01 DBMET00637 0.207 0.01 DBMET00698 0.26 0.005 DBMET00699 0.31 0.004 DBMET00700 0.299 0.004 DBMET00701 0.405 0.003 DBMET00702 | DBMET00702 | |
| 0.116 | 0.023 | 0.245 | Keratolytic | 0.191 0.009 DBMET00637 0.235 0.006 DBMET00698 0.228 0.006 DBMET00699 0.229 0.006 DBMET00700 0.245 0.005 DBMET00701 0.238 0.005 DBMET00702 | DBMET00701 | |
| 0.118 | 0.025 | 0.118 | Inducible nitric-oxide synthase inhibitor | 0.114 0.027 DBMET00637 0.083 0.057 DBMET00699 0.092 0.045 DBMET00700 0.08 0.062 DBMET00702 | ||
| 0.245 | 0.152 | 0.38 | Immunosuppressant | 0.373 0.075 DBMET00637 0.366 0.078 DBMET00698 0.366 0.079 DBMET00699 0.38 0.072 DBMET00700 0.35 0.087 DBMET00701 0.349 0.087 DBMET00702 | DBMET00700 | |
| 0.154 | 0.062 | 0.214 | Cell wall synthesis inhibitor | 0.126 0.091 DBMET00637 0.184 0.037 DBMET00698 0.2 0.03 DBMET00699 0.214 0.025 DBMET00700 0.136 0.079 DBMET00701 0.152 0.064 DBMET00702 | DBMET00700 | |
| 0.291 | 0.204 | 0.753 | Caspase 9 stimulant | 0.745 0.018 DBMET00637 0.605 0.035 DBMET00698 0.469 0.073 DBMET00699 0.485 0.066 DBMET00700 0.753 0.017 DBMET00701 0.586 0.038 DBMET00702 | DBMET00701 | |
| 0.11 | 0.024 | 0.112 | Carbonic anhydrase V inhibitor | 0.112 0.023 DBMET00637 0.061 0.052 DBMET00698 0.076 0.038 DBMET00699 0.078 0.036 DBMET00700 0.069 0.044 DBMET00702 | DBMET00637 | |
| 0.125 | 0.04 | 0.15 | Urease inhibitor | 0.15 0.023 DBMET00637 0.114 0.051 DBMET00699 0.116 0.049 DBMET00700 0.114 0.051 DBMET00702 | DBMET00637 | |
| 0.107 | 0.022 | 0.129 | D-Ala-D-Ala ligase inhibitor | 0.11 0.019 DBMET00637 0.096 0.034 DBMET00698 0.128 0.01 DBMET00699 0.129 0.01 DBMET00700 0.086 0.052 DBMET00701 0.113 0.017 DBMET00702 | DBMET00700 | |
| 0.101 | 0.016 | 0.101 | Beta adrenoreceptor antagonist | 0.09 0.021 DBMET00637 0.063 0.05 DBMET00698 0.073 0.034 DBMET00699 0.076 0.031 DBMET00700 0.067 0.043 DBMET00701 0.078 0.028 DBMET00702 | ||
| 0.106 | 0.023 | 0.106 | Carbonic anhydrase VA inhibitor | 0.103 0.024 DBMET00637 0.068 0.049 DBMET00698 0.078 0.038 DBMET00699 0.08 0.037 DBMET00700 0.062 0.056 DBMET00701 0.072 0.044 DBMET00702 | ||
| 0.138 | 0.056 | 0.254 | Aldehyde dehydrogenase inhibitor | 0.254 0.017 DBMET00637 0.167 0.038 DBMET00698 0.241 0.02 DBMET00699 0.174 0.035 DBMET00700 0.123 0.068 DBMET00702 | DBMET00637 | |
| 0.11 | 0.03 | 0.11 | Adrenaline agonist | 0.101 0.036 DBMET00637 0.086 0.05 DBMET00698 0.088 0.048 DBMET00699 0.086 0.05 DBMET00700 | ||
| 0.159 | 0.08 | 0.274 | Neurotensin receptor agonist | 0.171 0.06 DBMET00637 0.2 0.035 DBMET00698 0.274 0.017 DBMET00699 0.247 0.021 DBMET00700 0.183 0.046 DBMET00701 0.254 0.02 DBMET00702 | DBMET00699 | |
| 0.214 | 0.136 | 0.388 | Insulysin inhibitor | 0.351 0.034 DBMET00637 0.292 0.063 DBMET00698 0.388 0.024 DBMET00699 0.387 0.024 DBMET00700 0.256 0.091 DBMET00701 0.364 0.03 DBMET00702 | DBMET00699 | |
| 0.09 | 0.012 | 0.09 | Plasminogen activator inhibitor antagonist | 0.052 0.03 DBMET00699 0.07 0.019 DBMET00700 0.063 0.022 DBMET00702 | ||
| 0.136 | 0.063 | 0.399 | Toll-Like receptor 2 antagonist | 0.211 0.019 DBMET00637 0.197 0.025 DBMET00698 0.33 0.004 DBMET00699 0.344 0.004 DBMET00700 0.225 0.014 DBMET00701 0.399 0.003 DBMET00702 | DBMET00702 | |
| 0.091 | 0.019 | 0.102 | Carbonic anhydrase VB inhibitor | 0.102 0.015 DBMET00637 0.054 0.04 DBMET00698 0.064 0.032 DBMET00699 0.066 0.03 DBMET00700 | DBMET00637 | |
| 0.141 | 0.07 | 0.168 | Ca2+-transporting ATPase inhibitor | 0.168 0.014 DBMET00637 0.167 0.016 DBMET00698 0.165 0.018 DBMET00699 0.167 0.016 DBMET00700 0.155 0.032 DBMET00701 0.153 0.036 DBMET00702 | DBMET00637 | |
| 0.123 | 0.052 | 0.322 | Mucolytic | 0.212 0.011 DBMET00637 0.174 0.021 DBMET00698 0.247 0.007 DBMET00699 0.269 0.005 DBMET00700 0.223 0.009 DBMET00701 0.322 0.004 DBMET00702 | DBMET00702 | |
| 0.087 | 0.018 | 0.125 | Glutamate (mGluR6) antagonist | 0.075 0.031 DBMET00637 0.096 0.012 DBMET00698 0.123 0.005 DBMET00699 0.125 0.005 DBMET00700 0.076 0.029 DBMET00701 0.096 0.012 DBMET00702 | DBMET00700 | |
| 0.114 | 0.046 | 0.166 | Anabolic | 0.159 0.013 DBMET00637 0.166 0.011 DBMET00698 0.146 0.02 DBMET00699 0.142 0.022 DBMET00700 0.137 0.026 DBMET00701 0.11 0.05 DBMET00702 | DBMET00698 | |
| 0.113 | 0.046 | 0.113 | Potassium channel (Ca-activated) activator | 0.099 0.056 DBMET00699 0.093 0.062 DBMET00700 | ||
| 0.155 | 0.092 | 0.214 | Dual specificity phosphatase 3 inhibitor | 0.184 0.07 DBMET00699 0.214 0.054 DBMET00700 0.13 0.116 DBMET00701 0.205 0.058 DBMET00702 | DBMET00700 | |
| 0.156 | 0.095 | 0.277 | Phospholipase C inhibitor | 0.232 0.029 DBMET00637 0.267 0.022 DBMET00698 0.277 0.021 DBMET00699 0.272 0.021 DBMET00700 0.198 0.045 DBMET00701 0.201 0.043 DBMET00702 | DBMET00699 | |
| 0.244 | 0.183 | 0.387 | Antibacterial | 0.375 0.088 DBMET00637 0.295 0.139 DBMET00698 0.358 0.097 DBMET00699 0.387 0.083 DBMET00700 0.27 0.159 DBMET00701 0.334 0.112 DBMET00702 | DBMET00700 | |
| 0.116 | 0.055 | 0.315 | Aminopeptidase B inhibitor | 0.183 0.026 DBMET00637 0.182 0.026 DBMET00698 0.315 0.008 DBMET00699 0.299 0.009 DBMET00700 0.097 0.067 DBMET00701 0.22 0.017 DBMET00702 | DBMET00699 | |
| 0.257 | 0.197 | 0.462 | Calcium channel L-type activator | 0.426 0.065 DBMET00637 0.446 0.053 DBMET00698 0.462 0.045 DBMET00699 0.4 0.081 DBMET00700 0.358 0.111 DBMET00701 0.38 0.095 DBMET00702 | DBMET00699 | |
| 0.105 | 0.047 | 0.179 | Alcohol dehydrogenase inhibitor | 0.179 0.015 DBMET00637 0.126 0.031 DBMET00698 0.153 0.019 DBMET00699 0.142 0.023 DBMET00700 0.081 0.078 DBMET00701 0.099 0.054 DBMET00702 | DBMET00637 | |
| 0.136 | 0.078 | 0.342 | Lipid peroxidase inhibitor | 0.308 0.018 DBMET00637 0.332 0.015 DBMET00698 0.182 0.05 DBMET00699 0.217 0.035 DBMET00700 0.342 0.014 DBMET00701 0.21 0.038 DBMET00702 | DBMET00701 | |
| 0.217 | 0.16 | 0.466 | Apoptosis antagonist | 0.466 0.025 DBMET00637 0.262 0.116 DBMET00698 0.383 0.043 DBMET00699 0.414 0.034 DBMET00700 0.29 0.092 DBMET00701 0.393 0.04 DBMET00702 | DBMET00637 | |
| 0.087 | 0.037 | 0.224 | Phosphofructokinase-1 inhibitor | 0.154 0.017 DBMET00637 0.224 0.009 DBMET00698 0.199 0.011 DBMET00699 0.218 0.009 DBMET00700 0.155 0.017 DBMET00701 0.134 0.021 DBMET00702 | DBMET00698 | |
| 0.147 | 0.097 | 0.199 | Dual specificity phosphatase inhibitor | 0.175 0.071 DBMET00699 0.199 0.055 DBMET00700 0.187 0.062 DBMET00702 | DBMET00700 | |
| 0.093 | 0.044 | 0.094 | Myeloperoxidase inhibitor | 0.094 0.043 DBMET00637 | DBMET00637 | |
| 0.056 | 0.009 | 0.076 | Glutamate (mGluR8) agonist | 0.048 0.013 DBMET00637 0.046 0.015 DBMET00698 0.064 0.006 DBMET00699 0.076 0.004 DBMET00700 0.043 0.019 DBMET00701 0.059 0.007 DBMET00702 | DBMET00700 | |
| 0.126 | 0.081 | 0.188 | Sphingosine 1-phosphate receptor 2 antagonist | 0.172 0.019 DBMET00637 0.155 0.034 DBMET00698 0.176 0.017 DBMET00699 0.188 0.011 DBMET00700 0.148 0.044 DBMET00701 0.169 0.022 DBMET00702 | DBMET00700 | |
| 0.099 | 0.054 | 0.281 | Uric acid excretion stimulant | 0.093 0.06 DBMET00637 0.096 0.057 DBMET00698 0.259 0.006 DBMET00699 0.281 0.005 DBMET00700 0.088 0.068 DBMET00701 0.226 0.01 DBMET00702 | DBMET00700 | |
| 0.263 | 0.219 | 0.263 | MAP kinase 1 inhibitor | |||
| 0.07 | 0.026 | 0.081 | Beta 1 adrenoreceptor antagonist | 0.081 0.017 DBMET00637 0.062 0.034 DBMET00699 0.065 0.031 DBMET00700 0.049 0.048 DBMET00701 0.066 0.029 DBMET00702 | DBMET00637 | |
| 0.107 | 0.064 | 0.234 | Ferrochelatase inhibitor | 0.212 0.02 DBMET00637 0.213 0.02 DBMET00698 0.213 0.02 DBMET00699 0.234 0.016 DBMET00700 0.089 0.084 DBMET00701 0.089 0.084 DBMET00702 | DBMET00700 | |
| 0.064 | 0.023 | 0.083 | Carbonic anhydrase XIV inhibitor | 0.06 0.025 DBMET00637 0.049 0.034 DBMET00698 0.067 0.021 DBMET00699 0.07 0.02 DBMET00700 0.06 0.025 DBMET00701 0.083 0.016 DBMET00702 | DBMET00702 | |
| 0.046 | 0.005 | 0.057 | Thyroid hormone agonist | 0.052 0.004 DBMET00637 0.042 0.005 DBMET00698 0.054 0.004 DBMET00699 0.057 0.004 DBMET00700 0.027 0.016 DBMET00701 0.035 0.008 DBMET00702 | DBMET00700 | |
| 0.104 | 0.064 | 0.352 | Expectorant | 0.21 0.018 DBMET00637 0.159 0.032 DBMET00698 0.249 0.013 DBMET00699 0.28 0.01 DBMET00700 0.235 0.014 DBMET00701 0.352 0.006 DBMET00702 | DBMET00702 | |
| 0.063 | 0.024 | 0.078 | Leukotriene C antagonist | 0.07 0.014 DBMET00637 0.071 0.013 DBMET00698 0.078 0.009 DBMET00699 0.077 0.009 DBMET00700 0.058 0.033 DBMET00701 0.063 0.023 DBMET00702 | DBMET00699 | |
| 0.078 | 0.039 | 0.197 | HIV-1 integrase inhibitor | 0.197 0.005 DBMET00637 0.113 0.018 DBMET00698 0.07 0.049 DBMET00699 0.102 0.024 DBMET00700 0.118 0.016 DBMET00701 0.082 0.036 DBMET00702 | DBMET00637 | |
| 0.08 | 0.042 | 0.268 | Aminopeptidase I inhibitor | 0.134 0.016 DBMET00637 0.135 0.015 DBMET00698 0.268 0.004 DBMET00699 0.25 0.004 DBMET00700 0.072 0.051 DBMET00701 0.16 0.011 DBMET00702 | DBMET00699 | |
| 0.061 | 0.023 | 0.065 | Beta 2 adrenoreceptor antagonist | 0.065 0.02 DBMET00637 0.051 0.034 DBMET00698 0.06 0.024 DBMET00699 0.062 0.022 DBMET00700 0.048 0.039 DBMET00701 0.057 0.027 DBMET00702 | DBMET00637 | |
| 0.066 | 0.029 | 0.071 | Beta 2 adrenoreceptor agonist | 0.071 0.017 DBMET00637 0.066 0.029 DBMET00698 0.068 0.024 DBMET00699 0.068 0.024 DBMET00700 0.059 0.056 DBMET00701 0.061 0.047 DBMET00702 | DBMET00637 | |
| 0.092 | 0.057 | 0.305 | Triose-phosphate isomerase inhibitor | 0.187 0.012 DBMET00637 0.305 0.005 DBMET00698 0.164 0.016 DBMET00699 0.171 0.015 DBMET00700 0.161 0.017 DBMET00701 0.094 0.054 DBMET00702 | DBMET00698 | |
| 0.099 | 0.064 | 0.226 | 5-Lipoxygenase inhibitor | 0.198 0.025 DBMET00637 0.096 0.067 DBMET00698 0.187 0.027 DBMET00699 0.226 0.02 DBMET00700 0.122 0.049 DBMET00701 0.207 0.023 DBMET00702 | DBMET00700 | |
| 0.049 | 0.014 | 0.049 | Bombesin 1 receptor antagonist | |||
| 0.051 | 0.017 | 0.15 | Dopamine D5 agonist | 0.15 0.003 DBMET00637 0.088 0.005 DBMET00698 0.106 0.004 DBMET00699 0.11 0.004 DBMET00700 0.057 0.013 DBMET00701 0.069 0.009 DBMET00702 | DBMET00637 | |
| 0.079 | 0.045 | 0.161 | GABA B receptor agonist | 0.127 0.006 DBMET00637 0.157 0.004 DBMET00698 0.144 0.005 DBMET00699 0.15 0.004 DBMET00700 0.161 0.004 DBMET00701 0.147 0.004 DBMET00702 | DBMET00701 | |
| 0.143 | 0.112 | 0.246 | DNA methyltransferase I inhibitor | 0.246 0.049 DBMET00637 0.144 0.111 DBMET00700 0.208 0.065 DBMET00701 0.215 0.062 DBMET00702 | DBMET00637 | |
| 0.155 | 0.127 | 0.404 | Insulin sensitizer | 0.215 0.059 DBMET00637 0.374 0.008 DBMET00698 0.388 0.007 DBMET00699 0.404 0.006 DBMET00700 0.344 0.01 DBMET00701 0.356 0.009 DBMET00702 | DBMET00700 | |
| 0.039 | 0.011 | 0.075 | Glutamate (mGluR3) agonist | 0.036 0.014 DBMET00637 0.042 0.008 DBMET00698 0.075 0.003 DBMET00699 0.069 0.003 DBMET00700 0.036 0.015 DBMET00701 0.06 0.004 DBMET00702 | DBMET00699 | |
| 0.044 | 0.019 | 0.059 | Arginase inhibitor | 0.059 0.011 DBMET00698 0.051 0.014 DBMET00699 0.057 0.012 DBMET00700 0.037 0.025 DBMET00701 | DBMET00698 | |
| 0.048 | 0.023 | 0.049 | Beta adrenoreceptor agonist | 0.049 0.019 DBMET00637 0.048 0.022 DBMET00698 0.047 0.024 DBMET00699 0.047 0.025 DBMET00700 | DBMET00637 | |
| 0.065 | 0.043 | 0.084 | Beta 3 adrenoreceptor antagonist | 0.084 0.02 DBMET00637 0.064 0.045 DBMET00698 0.067 0.039 DBMET00699 0.068 0.038 DBMET00700 0.062 0.049 DBMET00701 0.065 0.042 DBMET00702 | DBMET00637 | |
| 0.06 | 0.038 | 0.09 | Xanthine dehydrogenase inhibitor | 0.051 0.045 DBMET00637 0.083 0.023 DBMET00699 0.09 0.019 DBMET00700 0.08 0.025 DBMET00702 | DBMET00700 | |
| 0.054 | 0.033 | 0.086 | Vanilloid 2 antagonist | 0.086 0.007 DBMET00637 0.053 0.035 DBMET00698 0.054 0.033 DBMET00699 0.069 0.015 DBMET00700 0.075 0.011 DBMET00701 0.076 0.011 DBMET00702 | DBMET00637 | |
| 0.099 | 0.079 | 0.222 | Chelator | 0.222 0.021 DBMET00637 0.157 0.033 DBMET00698 0.134 0.043 DBMET00699 0.183 0.028 DBMET00700 0.164 0.031 DBMET00701 0.142 0.039 DBMET00702 | DBMET00637 | |
| 0.095 | 0.076 | 0.202 | Adenylate kinase inhibitor | 0.202 0.015 DBMET00637 0.134 0.034 DBMET00698 0.139 0.031 DBMET00699 0.147 0.027 DBMET00700 0.093 0.079 DBMET00701 0.096 0.073 DBMET00702 | DBMET00637 | |
| 0.061 | 0.042 | 0.146 | Carbamoyl phosphate synthetase inhibitor | 0.099 0.021 DBMET00637 0.146 0.012 DBMET00698 0.08 0.028 DBMET00699 0.09 0.024 DBMET00700 0.092 0.023 DBMET00701 | DBMET00698 | |
| 0.109 | 0.09 | 0.365 | Cyclooxygenase 3 inhibitor | 0.191 0.022 DBMET00637 0.21 0.015 DBMET00698 0.344 0.005 DBMET00699 0.339 0.005 DBMET00700 0.218 0.014 DBMET00701 0.365 0.004 DBMET00702 | DBMET00702 | |
| 0.14 | 0.121 | 0.28 | Hepatoprotectant | 0.28 0.035 DBMET00637 0.211 0.059 DBMET00698 0.216 0.056 DBMET00699 0.242 0.045 DBMET00700 0.242 0.046 DBMET00701 0.246 0.044 DBMET00702 | DBMET00637 | |
| 0.087 | 0.071 | 0.232 | Prolactin inhibitor | 0.186 0.011 DBMET00637 0.186 0.011 DBMET00698 0.232 0.005 DBMET00699 0.221 0.006 DBMET00700 0.128 0.033 DBMET00701 0.171 0.015 DBMET00702 | DBMET00699 | |
| 0.086 | 0.071 | 0.214 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.214 0.014 DBMET00637 0.174 0.02 DBMET00698 0.207 0.015 DBMET00699 0.214 0.014 DBMET00700 0.108 0.047 DBMET00701 0.128 0.035 DBMET00702 | DBMET00700 | |
| 0.037 | 0.022 | 0.053 | Glutamate (mGluR8) antagonist | 0.037 0.021 DBMET00698 0.053 0.007 DBMET00699 0.053 0.007 DBMET00700 0.043 0.013 DBMET00702 | DBMET00700 | |
| 0.036 | 0.021 | 0.039 | Prostacyclin antagonist | 0.039 0.019 DBMET00699 0.035 0.021 DBMET00700 | DBMET00699 | |
| 0.065 | 0.051 | 0.065 | Potassium channel large-conductance Ca-activated activator | |||
| 0.034 | 0.021 | 0.135 | Catechol O-methyltransferase inhibitor | 0.135 0.004 DBMET00637 0.033 0.022 DBMET00699 0.06 0.006 DBMET00700 0.035 0.019 DBMET00701 0.042 0.012 DBMET00702 | DBMET00637 | |
| 0.101 | 0.089 | 0.136 | MAO inhibitor | 0.136 0.067 DBMET00637 | DBMET00637 | |
| 0.017 | 0.005 | 0.017 | Glutamate (mGluR6) agonist | 0.012 0.009 DBMET00637 0.013 0.008 DBMET00699 0.017 0.005 DBMET00700 0.011 0.01 DBMET00702 | ||
| 0.038 | 0.026 | 0.038 | Diamine oxidase inhibitor | 0.038 0.026 DBMET00637 | ||
| 0.035 | 0.023 | 0.037 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.031 0.029 DBMET00698 0.037 0.019 DBMET00699 0.034 0.024 DBMET00700 | DBMET00699 | |
| 0.02 | 0.01 | 0.04 | Estrogen-related receptor gamma agonist | 0.032 0.004 DBMET00637 0.025 0.005 DBMET00698 0.04 0.003 DBMET00699 0.036 0.003 DBMET00700 0.023 0.007 DBMET00702 | DBMET00699 | |
| 0.098 | 0.088 | 0.205 | DNA polymerase I inhibitor | 0.205 0.026 DBMET00637 0.149 0.05 DBMET00698 0.166 0.041 DBMET00699 0.2 0.028 DBMET00700 0.164 0.042 DBMET00701 0.178 0.036 DBMET00702 | DBMET00637 | |
| 0.068 | 0.059 | 0.218 | Glutamate dehydrogenase inhibitor | 0.159 0.014 DBMET00637 0.2 0.01 DBMET00698 0.202 0.01 DBMET00699 0.218 0.009 DBMET00700 0.113 0.025 DBMET00701 0.114 0.025 DBMET00702 | DBMET00700 | |
| 0.04 | 0.032 | 0.067 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.067 0.005 DBMET00637 0.05 0.014 DBMET00698 0.05 0.014 DBMET00699 0.055 0.01 DBMET00700 0.043 0.025 DBMET00701 0.043 0.025 DBMET00702 | DBMET00637 | |
| 0.012 | 0.004 | 0.018 | Thyroid hormone beta agonist | 0.009 0.006 DBMET00637 0.009 0.006 DBMET00698 0.015 0.004 DBMET00699 0.018 0.004 DBMET00700 | DBMET00700 | |
| 0.049 | 0.041 | 0.107 | Ribonucleoside-diphosphate reductase inhibitor | 0.062 0.033 DBMET00637 0.047 0.043 DBMET00698 0.107 0.018 DBMET00699 0.106 0.018 DBMET00700 0.059 0.035 DBMET00702 | DBMET00699 | |
| 0.035 | 0.028 | 0.035 | Cholecystokinin A antagonist | |||
| 0.069 | 0.062 | 0.069 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.165 | 0.159 | 0.61 | 5 Hydroxytryptamine release stimulant | 0.61 0.014 DBMET00637 0.39 0.048 DBMET00698 0.604 0.014 DBMET00699 0.524 0.024 DBMET00700 0.314 0.066 DBMET00701 0.545 0.021 DBMET00702 | DBMET00637 | |
| 0.038 | 0.032 | 0.038 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.048 | 0.043 | 0.105 | Ribonucleotide reductase inhibitor | 0.063 0.035 DBMET00637 0.046 0.045 DBMET00698 0.105 0.019 DBMET00699 0.105 0.019 DBMET00700 0.06 0.037 DBMET00702 | DBMET00700 | |
| 0.051 | 0.046 | 0.071 | DNA helicase inhibitor | 0.069 0.018 DBMET00698 0.071 0.017 DBMET00699 0.07 0.017 DBMET00700 0.067 0.019 DBMET00701 0.068 0.018 DBMET00702 | DBMET00699 | |
| 0.1 | 0.096 | 0.428 | Amylase inhibitor | 0.258 0.026 DBMET00637 0.391 0.01 DBMET00698 0.342 0.014 DBMET00699 0.349 0.013 DBMET00700 0.428 0.008 DBMET00701 0.373 0.011 DBMET00702 | DBMET00701 | |
| 0.096 | 0.093 | 0.323 | Cholesterol synthesis inhibitor | 0.215 0.023 DBMET00637 0.299 0.012 DBMET00698 0.296 0.012 DBMET00699 0.307 0.011 DBMET00700 0.323 0.009 DBMET00701 0.32 0.009 DBMET00702 | DBMET00701 | |
| 0.055 | 0.052 | 0.058 | Glucagon-like peptide 1 agonist | 0.058 0.05 DBMET00699 | DBMET00699 | |
| 0.052 | 0.05 | 0.121 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.084 0.023 DBMET00637 0.121 0.012 DBMET00698 0.09 0.02 DBMET00699 0.09 0.02 DBMET00700 0.092 0.019 DBMET00701 0.068 0.032 DBMET00702 | DBMET00698 | |
| 0.079 | 0.077 | 0.13 | NADH dehydrogenase inhibitor | 0.13 0.024 DBMET00637 0.115 0.032 DBMET00698 0.115 0.032 DBMET00699 0.126 0.026 DBMET00700 0.093 0.053 DBMET00701 0.093 0.053 DBMET00702 | DBMET00637 | |
| 0.05 | 0.048 | 0.08 | Sphingosine 1-phosphate receptor 5 agonist | 0.08 0.013 DBMET00699 0.077 0.013 DBMET00700 0.059 0.027 DBMET00702 | DBMET00699 | |
| 0.018 | 0.017 | 0.023 | Antibiotic Anthracycline-like | 0.023 0.006 DBMET00637 0.019 0.014 DBMET00698 0.019 0.013 DBMET00699 0.018 0.016 DBMET00700 0.018 0.014 DBMET00701 0.019 0.014 DBMET00702 | DBMET00637 | |
| 0.026 | 0.025 | 0.026 | Cholecystokinin B antagonist | |||
| 0.08 | 0.08 | 0.094 | MAO A inhibitor | 0.094 0.069 DBMET00637 | DBMET00637 | |
| 0.043 | 0.043 | 0.089 | Glucose-6-phosphate isomerase inhibitor | 0.07 0.012 DBMET00637 0.089 0.006 DBMET00698 0.081 0.008 DBMET00699 0.086 0.007 DBMET00700 0.066 0.014 DBMET00701 0.06 0.019 DBMET00702 | DBMET00698 | |
| 0.023 | 0.023 | 0.047 | Vanilloid 2 agonist | 0.042 0.004 DBMET00637 0.033 0.007 DBMET00698 0.044 0.004 DBMET00699 0.047 0.003 DBMET00700 0.024 0.02 DBMET00701 0.033 0.007 DBMET00702 | DBMET00700 | |
| 0.057 | 0.058 | 0.128 | Sphingosine 1-phosphate receptor 4 agonist | 0.062 0.052 DBMET00698 0.128 0.014 DBMET00699 0.114 0.019 DBMET00700 0.065 0.049 DBMET00702 | DBMET00699 | |
| 0.045 | 0.048 | 0.153 | Aconitate hydratase inhibitor | 0.086 0.012 DBMET00637 0.15 0.004 DBMET00698 0.151 0.004 DBMET00699 0.153 0.004 DBMET00700 0.083 0.013 DBMET00701 0.083 0.013 DBMET00702 | DBMET00700 | |
| 0.037 | 0.04 | 0.093 | Kainate receptor agonist | 0.049 0.015 DBMET00637 0.056 0.009 DBMET00698 0.088 0.003 DBMET00699 0.093 0.003 DBMET00700 0.047 0.018 DBMET00701 0.072 0.004 DBMET00702 | DBMET00700 | |
| 0.123 | 0.126 | 0.307 | Interferon gamma antagonist | 0.207 0.038 DBMET00637 0.307 0.019 DBMET00698 0.239 0.03 DBMET00699 0.249 0.029 DBMET00700 0.301 0.02 DBMET00701 0.232 0.032 DBMET00702 | DBMET00698 | |
| 0.014 | 0.017 | 0.02 | Thyroid hormone alpha agonist | 0.015 0.013 DBMET00637 0.016 0.011 DBMET00698 0.018 0.009 DBMET00699 0.02 0.007 DBMET00700 0.015 0.013 DBMET00702 | DBMET00700 | |
| 0.062 | 0.065 | 0.168 | Cathepsin G inhibitor | 0.083 0.042 DBMET00637 0.083 0.042 DBMET00698 0.168 0.019 DBMET00699 0.153 0.02 DBMET00700 0.126 0.025 DBMET00702 | DBMET00699 | |
| 0.055 | 0.059 | 0.166 | Leukotriene antagonist | 0.074 0.037 DBMET00637 0.121 0.015 DBMET00698 0.165 0.008 DBMET00699 0.166 0.008 DBMET00700 0.112 0.017 DBMET00701 0.153 0.01 DBMET00702 | DBMET00700 | |
| 0.013 | 0.018 | 0.031 | Aminopeptidase A inhibitor | 0.031 0.006 DBMET00699 0.028 0.007 DBMET00700 | DBMET00699 | |
| 0.012 | 0.018 | 0.023 | Thyroid hormone alpha antagonist | 0.014 0.013 DBMET00698 0.02 0.008 DBMET00699 0.023 0.006 DBMET00700 0.014 0.013 DBMET00702 | DBMET00700 | |
| 0.027 | 0.033 | 0.156 | Fumarate hydratase inhibitor | 0.077 0.007 DBMET00637 0.156 0.004 DBMET00698 0.085 0.006 DBMET00699 0.095 0.006 DBMET00700 0.093 0.006 DBMET00701 0.056 0.011 DBMET00702 | DBMET00698 | |
| 0.046 | 0.053 | 0.227 | Argininosuccinate synthase inhibitor | 0.148 0.012 DBMET00637 0.226 0.006 DBMET00698 0.216 0.007 DBMET00699 0.227 0.006 DBMET00700 0.12 0.015 DBMET00701 0.113 0.016 DBMET00702 | DBMET00700 | |
| 0.111 | 0.119 | 0.182 | Mannose-6-phosphate isomerase inhibitor | 0.182 0.041 DBMET00637 0.12 0.1 DBMET00698 0.131 0.084 DBMET00699 0.162 0.055 DBMET00700 0.135 0.079 DBMET00701 0.149 0.065 DBMET00702 | DBMET00637 | |
| 0.081 | 0.088 | 0.345 | UDP-glucose 4-epimerase inhibitor | 0.345 0.008 DBMET00637 0.138 0.033 DBMET00698 0.138 0.033 DBMET00699 0.147 0.03 DBMET00700 0.085 0.081 DBMET00701 0.085 0.081 DBMET00702 | DBMET00637 | |
| 0.076 | 0.084 | 0.226 | Vanilloid agonist | 0.16 0.009 DBMET00637 0.104 0.029 DBMET00698 0.157 0.01 DBMET00699 0.224 0.005 DBMET00700 0.14 0.012 DBMET00701 0.226 0.005 DBMET00702 | DBMET00702 | |
| 0.018 | 0.027 | 0.026 | Beta 1 adrenoreceptor agonist | 0.021 0.018 DBMET00637 0.026 0.011 DBMET00699 0.026 0.011 DBMET00700 0.022 0.018 DBMET00702 | DBMET00700 | |
| 0.048 | 0.057 | 0.102 | Biliverdin reductase inhibitor | 0.091 0.021 DBMET00637 0.088 0.023 DBMET00698 0.088 0.023 DBMET00699 0.102 0.018 DBMET00700 | DBMET00700 | |
| 0.077 | 0.086 | 0.163 | Granulocyte macrophage colony stimulating factor agonist | 0.127 0.012 DBMET00637 0.096 0.041 DBMET00698 0.121 0.015 DBMET00699 0.137 0.008 DBMET00700 0.131 0.01 DBMET00701 0.163 0.004 DBMET00702 | DBMET00702 | |
| 0.175 | 0.185 | 0.377 | Thyroid hormone antagonist | 0.335 0.079 DBMET00699 0.356 0.071 DBMET00700 0.377 0.064 DBMET00702 | DBMET00702 | |
| 0.003 | 0.015 | 0.006 | Insulin like growth factor 3 antagonist | 0.006 0.005 DBMET00637 | DBMET00637 | |
| 0.006 | 0.019 | 0.013 | Thromboxane agonist | 0.013 0.005 DBMET00637 0.013 0.006 DBMET00699 0.013 0.005 DBMET00700 | DBMET00700 | |
| 0.047 | 0.061 | 0.084 | Carbonic anhydrase stimulant | 0.053 0.049 DBMET00637 0.058 0.042 DBMET00698 0.077 0.027 DBMET00699 0.084 0.024 DBMET00700 0.064 0.036 DBMET00702 | DBMET00700 | |
| 0.044 | 0.059 | 0.122 | Leukotriene B4 antagonist | 0.065 0.023 DBMET00637 0.097 0.011 DBMET00698 0.115 0.008 DBMET00699 0.119 0.007 DBMET00700 0.103 0.01 DBMET00701 0.122 0.007 DBMET00702 | DBMET00702 | |
| 0.049 | 0.064 | 0.07 | Adenine nucleotide translocase inhibitor | 0.059 0.029 DBMET00637 0.056 0.037 DBMET00698 0.064 0.021 DBMET00699 0.07 0.015 DBMET00700 0.056 0.038 DBMET00701 0.063 0.024 DBMET00702 | DBMET00700 | |
| 0.028 | 0.043 | 0.036 | Growth factor receptor-bound protein 2 antagonist | 0.036 0.021 DBMET00699 0.036 0.023 DBMET00700 | DBMET00700 | |
| 0.127 | 0.142 | 0.24 | DNA methylase inhibitor | 0.24 0.054 DBMET00637 0.143 0.124 DBMET00700 0.211 0.072 DBMET00701 0.209 0.073 DBMET00702 | DBMET00637 | |
| 0.024 | 0.041 | 0.148 | ATP citrate lysase inhibitor | 0.049 0.008 DBMET00637 0.148 0.003 DBMET00698 0.113 0.003 DBMET00699 0.109 0.003 DBMET00700 0.073 0.004 DBMET00701 0.061 0.005 DBMET00702 | DBMET00698 | |
| 0.078 | 0.096 | 0.236 | Carbonic anhydrase III inhibitor | 0.218 0.013 DBMET00637 0.169 0.022 DBMET00698 0.236 0.011 DBMET00699 0.234 0.011 DBMET00700 0.153 0.027 DBMET00701 0.216 0.014 DBMET00702 | DBMET00699 | |
| 0.043 | 0.061 | 0.063 | Alpha-mannosidase inhibitor | 0.054 0.036 DBMET00637 0.063 0.023 DBMET00698 0.061 0.025 DBMET00699 0.06 0.027 DBMET00700 0.051 0.043 DBMET00701 0.049 0.046 DBMET00702 | DBMET00698 | |
| 0.049 | 0.067 | 0.117 | Purinergic P2X1 antagonist | 0.117 0.012 DBMET00637 0.104 0.015 DBMET00698 0.095 0.018 DBMET00699 0.097 0.017 DBMET00700 0.068 0.034 DBMET00701 0.062 0.04 DBMET00702 | DBMET00637 | |
| 0.01 | 0.029 | 0.015 | Thromboxane A2 agonist | 0.015 0.012 DBMET00700 | DBMET00700 | |
| 0.033 | 0.051 | 0.068 | Carbonic anhydrase VII inhibitor | 0.068 0.016 DBMET00637 | DBMET00637 | |
| 0.122 | 0.142 | 0.344 | Platelet adhesion inhibitor | 0.344 0.021 DBMET00637 0.138 0.121 DBMET00698 0.154 0.102 DBMET00699 0.179 0.083 DBMET00700 0.179 0.083 DBMET00701 0.2 0.071 DBMET00702 | DBMET00637 | |
| 0.016 | 0.037 | 0.046 | Prostaglandin F2 alpha agonist | 0.03 0.009 DBMET00637 0.046 0.005 DBMET00698 0.046 0.005 DBMET00699 0.043 0.005 DBMET00700 0.026 0.011 DBMET00701 0.026 0.011 DBMET00702 | DBMET00699 | |
| 0.027 | 0.049 | 0.246 | Glutamate (mGluR3) antagonist | 0.035 0.029 DBMET00637 0.045 0.015 DBMET00698 0.246 0.003 DBMET00699 0.216 0.003 DBMET00700 0.105 0.004 DBMET00702 | DBMET00699 | |
| 0.039 | 0.061 | 0.082 | Topoisomerase II beta inhibitor | 0.082 0.013 DBMET00637 0.053 0.029 DBMET00698 0.052 0.03 DBMET00701 | DBMET00637 | |
| 0.025 | 0.049 | 0.036 | RNA-directed RNA polymerase inhibitor | 0.036 0.022 DBMET00699 0.031 0.029 DBMET00700 | DBMET00699 | |
| 0.025 | 0.052 | 0.043 | Carboxypeptidase B inhibitor | 0.043 0.01 DBMET00699 0.042 0.011 DBMET00700 0.031 0.028 DBMET00702 | DBMET00699 | |
| 0.116 | 0.144 | 0.345 | Nitric oxide antagonist | 0.345 0.032 DBMET00637 0.218 0.061 DBMET00698 0.212 0.063 DBMET00699 0.242 0.054 DBMET00700 0.257 0.05 DBMET00701 0.252 0.051 DBMET00702 | DBMET00637 | |
| 0.009 | 0.037 | 0.024 | Endothelin B receptor antagonist | 0.021 0.012 DBMET00699 0.02 0.013 DBMET00700 0.024 0.01 DBMET00702 | DBMET00702 | |
| 0.05 | 0.08 | 0.216 | Catalase inhibitor | 0.216 0.012 DBMET00637 0.177 0.02 DBMET00698 0.215 0.013 DBMET00699 0.205 0.014 DBMET00700 0.139 0.029 DBMET00701 0.184 0.018 DBMET00702 | DBMET00637 | |
| 0.033 | 0.063 | 0.084 | Aldose reductase inhibitor | 0.057 0.034 DBMET00637 0.084 0.022 DBMET00698 0.061 0.032 DBMET00699 0.069 0.028 DBMET00700 0.078 0.024 DBMET00701 0.058 0.033 DBMET00702 | DBMET00698 | |
| 0.033 | 0.065 | 0.083 | Thromboxane antagonist | 0.08 0.02 DBMET00699 0.083 0.018 DBMET00700 0.049 0.043 DBMET00702 | DBMET00700 | |
| 0.035 | 0.068 | 0.065 | Lysophosphatidic acid 3 receptor antagonist | 0.06 0.022 DBMET00637 0.059 0.024 DBMET00698 0.064 0.019 DBMET00699 0.065 0.018 DBMET00700 0.052 0.033 DBMET00701 0.057 0.026 DBMET00702 | DBMET00700 | |
| 0.034 | 0.068 | 0.061 | Glutamate (mGluR group III) antagonist | 0.061 0.012 DBMET00699 0.056 0.015 DBMET00700 0.04 0.039 DBMET00702 | DBMET00699 | |
| 0.037 | 0.071 | 0.063 | Bombesin 2 receptor antagonist | 0.063 0.023 DBMET00699 0.056 0.027 DBMET00700 0.052 0.031 DBMET00702 | DBMET00699 | |
| 0.031 | 0.067 | 0.052 | Leukotriene C4 antagonist | 0.046 0.014 DBMET00637 0.047 0.013 DBMET00698 0.052 0.009 DBMET00699 0.05 0.01 DBMET00700 0.039 0.027 DBMET00702 | DBMET00699 | |
| 0.031 | 0.067 | 0.078 | Ornithine carbamoyltransferase inhibitor | 0.071 0.025 DBMET00699 0.078 0.022 DBMET00700 | DBMET00700 | |
| 0.03 | 0.066 | 0.05 | Mannosidase inhibitor | 0.042 0.037 DBMET00637 0.05 0.025 DBMET00698 0.048 0.027 DBMET00699 0.047 0.029 DBMET00700 | DBMET00698 | |
| 0.01 | 0.046 | 0.014 | Integrin beta6 antagonist | 0.014 0.01 DBMET00699 0.014 0.012 DBMET00700 | DBMET00700 | |
| 0.164 | 0.202 | 0.308 | Gastrin inhibitor | 0.229 0.106 DBMET00637 0.3 0.033 DBMET00698 0.308 0.028 DBMET00699 0.3 0.033 DBMET00700 0.257 0.072 DBMET00701 0.267 0.061 DBMET00702 | DBMET00699 | |
| 0.01 | 0.048 | 0.021 | Telomerase stimulant | 0.017 0.013 DBMET00637 0.016 0.015 DBMET00698 0.02 0.008 DBMET00699 0.021 0.006 DBMET00700 | DBMET00700 | |
| 0.01 | 0.048 | 0.017 | Vitamin D receptor agonist | 0.017 0.011 DBMET00698 | DBMET00698 | |
| 0.007 | 0.046 | 0.016 | Ileal bile acid transport inhibitor | 0.016 0.014 DBMET00699 0.015 0.014 DBMET00702 | DBMET00699 | |
| 0.057 | 0.097 | 0.075 | MDM2 inhibitor | 0.066 0.051 DBMET00637 0.075 0.026 DBMET00698 0.068 0.044 DBMET00699 0.069 0.041 DBMET00700 0.064 0.061 DBMET00701 | DBMET00698 | |
| 0.009 | 0.049 | 0.043 | Nicotinic acid receptor 1 antagonist | 0.021 0.008 DBMET00637 0.019 0.01 DBMET00698 0.043 0.003 DBMET00699 0.034 0.004 DBMET00700 0.016 0.015 DBMET00702 | DBMET00699 | |
| 0.038 | 0.079 | 0.087 | Selectin antagonist | 0.071 0.042 DBMET00699 0.087 0.033 DBMET00700 0.058 0.051 DBMET00702 | DBMET00700 | |
| 0.034 | 0.078 | 0.146 | Aminopeptidase microsomal inhibitor | 0.143 0.009 DBMET00699 0.146 0.008 DBMET00700 0.11 0.015 DBMET00702 | DBMET00700 | |
| 0.046 | 0.09 | 0.076 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.076 0.022 DBMET00637 0.057 0.049 DBMET00700 | DBMET00637 | |
| 0.073 | 0.118 | 0.159 | Bile acid receptor antagonist | 0.129 0.013 DBMET00637 0.114 0.026 DBMET00698 0.159 0.006 DBMET00699 0.155 0.007 DBMET00700 0.104 0.042 DBMET00701 0.138 0.01 DBMET00702 | DBMET00699 | |
| 0.02 | 0.065 | 0.035 | Estrogen-related receptor gamma antagonist | 0.035 0.008 DBMET00637 0.031 0.015 DBMET00698 0.031 0.014 DBMET00699 | DBMET00637 | |
| 0.032 | 0.078 | 0.087 | Acyl-CoA dehydrogenase inhibitor | 0.087 0.02 DBMET00637 0.058 0.034 DBMET00698 0.06 0.033 DBMET00699 0.069 0.027 DBMET00700 | DBMET00637 | |
| 0.099 | 0.145 | 0.351 | Protein-tyrosine phosphatase inhibitor | 0.186 0.053 DBMET00637 0.351 0.012 DBMET00698 0.224 0.038 DBMET00699 0.247 0.032 DBMET00700 0.313 0.017 DBMET00701 0.2 0.046 DBMET00702 | DBMET00698 | |
| 0.025 | 0.073 | 0.076 | Thromboxane A2 antagonist | 0.072 0.02 DBMET00699 0.076 0.017 DBMET00700 0.044 0.041 DBMET00702 | DBMET00700 | |
| 0.04 | 0.089 | 0.09 | Dihydroorotate oxidase inhibitor | 0.09 0.007 DBMET00637 0.065 0.022 DBMET00699 0.073 0.015 DBMET00700 | DBMET00637 | |
| 0.017 | 0.065 | 0.078 | 5-Alpha-reductase inhibitor | 0.076 0.013 DBMET00699 0.078 0.013 DBMET00700 0.044 0.021 DBMET00702 | DBMET00700 | |
| 0.027 | 0.076 | 0.046 | Aggrecanase 1 inhibitor | 0.046 0.018 DBMET00699 0.044 0.02 DBMET00700 0.039 0.027 DBMET00702 | DBMET00699 | |
| 0.013 | 0.063 | 0.061 | Endothelin receptor antagonist | 0.061 0.009 DBMET00699 0.061 0.009 DBMET00700 0.06 0.009 DBMET00702 | DBMET00700 | |
| 0.054 | 0.104 | 0.147 | Glycine receptor agonist | 0.09 0.028 DBMET00637 0.147 0.007 DBMET00698 0.129 0.01 DBMET00699 0.132 0.01 DBMET00700 0.128 0.01 DBMET00701 0.113 0.015 DBMET00702 | DBMET00698 | |
| 0.046 | 0.097 | 0.071 | Neuraminidase (influenza) inhibitor | 0.071 0.034 DBMET00698 0.06 0.055 DBMET00699 0.065 0.043 DBMET00700 0.067 0.039 DBMET00701 | DBMET00698 | |
| 0.008 | 0.059 | 0.042 | Prostaglandin H2 antagonist | 0.024 0.019 DBMET00698 0.038 0.007 DBMET00699 0.042 0.005 DBMET00700 0.036 0.008 DBMET00702 | DBMET00700 | |
| 0.041 | 0.093 | 0.069 | Sphingosine 1-phosphate receptor 1 antagonist | 0.053 0.045 DBMET00637 0.069 0.019 DBMET00699 0.06 0.029 DBMET00700 | DBMET00699 | |
| 0.012 | 0.065 | 0.058 | Glucagon receptor antagonist | 0.051 0.01 DBMET00699 0.058 0.008 DBMET00700 0.031 0.019 DBMET00702 | DBMET00700 | |
| 0.013 | 0.066 | 0.028 | Sodium/glucose cotransporter 2 inhibitor | 0.028 0.016 DBMET00637 0.025 0.021 DBMET00698 | DBMET00637 | |
| 0.061 | 0.114 | 0.12 | Glutathione S-transferase inhibitor | 0.12 0.023 DBMET00637 0.092 0.045 DBMET00698 0.1 0.037 DBMET00699 0.113 0.027 DBMET00700 0.084 0.055 DBMET00701 0.092 0.045 DBMET00702 | DBMET00637 | |
| 0.038 | 0.093 | 0.467 | Peroxisome proliferator-activated receptor gamma agonist | 0.066 0.053 DBMET00637 0.467 0.004 DBMET00698 0.31 0.004 DBMET00699 0.327 0.004 DBMET00700 0.372 0.004 DBMET00701 0.237 0.005 DBMET00702 | DBMET00698 | |
| 0.023 | 0.078 | 0.124 | Aminopeptidase N inhibitor | 0.122 0.009 DBMET00699 0.124 0.009 DBMET00700 0.089 0.015 DBMET00702 | DBMET00700 | |
| 0.021 | 0.076 | 0.307 | Peroxisome proliferator-activated receptor delta antagonist | 0.307 0.003 DBMET00698 0.154 0.005 DBMET00699 0.154 0.005 DBMET00700 0.243 0.004 DBMET00701 0.073 0.007 DBMET00702 | DBMET00698 | |
| 0.053 | 0.108 | 0.261 | Macrophage migration inhibitory factor inhibitor | 0.261 0.005 DBMET00637 0.139 0.019 DBMET00698 0.134 0.02 DBMET00699 0.13 0.022 DBMET00700 0.146 0.016 DBMET00701 0.142 0.018 DBMET00702 | DBMET00637 | |
| 0.015 | 0.07 | 0.024 | Lysophosphatidic acid receptor 1 agonist | 0.023 0.021 DBMET00699 0.024 0.02 DBMET00700 | DBMET00700 | |
| 0.027 | 0.082 | 0.063 | Neurotensin receptor antagonist | 0.063 0.023 DBMET00699 0.052 0.027 DBMET00700 0.041 0.036 DBMET00702 | DBMET00699 | |
| 0.036 | 0.092 | 0.1 | Neutrophil collagenase inhibitor | 0.058 0.053 DBMET00698 0.094 0.024 DBMET00699 0.1 0.022 DBMET00700 0.082 0.03 DBMET00702 | DBMET00700 | |
| 0.012 | 0.069 | 0.021 | Methylmalonyl-CoA mutase inhibitor | 0.02 0.009 DBMET00699 0.021 0.008 DBMET00700 | DBMET00700 | |
| 0.15 | 0.207 | 0.411 | 12-Lipoxygenase inhibitor | 0.411 0.036 DBMET00637 0.215 0.136 DBMET00698 0.335 0.063 DBMET00699 0.353 0.056 DBMET00700 0.27 0.098 DBMET00701 0.388 0.042 DBMET00702 | DBMET00637 | |
| 0.059 | 0.117 | 0.093 | Sphingosine 1-phosphate receptor antagonist | 0.082 0.041 DBMET00637 0.093 0.027 DBMET00699 0.084 0.039 DBMET00700 | DBMET00699 | |
| 0.023 | 0.081 | 0.051 | HIV-1 protease inhibitor | 0.045 0.027 DBMET00698 0.051 0.02 DBMET00699 0.051 0.02 DBMET00700 0.04 0.034 DBMET00702 | DBMET00700 | |
| 0.039 | 0.098 | 0.082 | Angiotensin-converting enzyme inhibitor | 0.082 0.013 DBMET00699 0.081 0.013 DBMET00700 0.065 0.024 DBMET00702 | DBMET00699 | |
| 0.004 | 0.063 | 0.036 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.034 0.005 DBMET00699 0.036 0.004 DBMET00700 0.019 0.008 DBMET00702 | DBMET00700 | |
| 0.04 | 0.098 | 0.159 | Leukotriene synthesis inhibitor | 0.159 0.008 DBMET00637 0.076 0.04 DBMET00698 0.113 0.019 DBMET00699 0.117 0.018 DBMET00700 0.07 0.044 DBMET00701 0.104 0.024 DBMET00702 | DBMET00637 | |
| 0.011 | 0.07 | 0.021 | Leukotriene B4 receptor 2 antagonist | 0.02 0.019 DBMET00699 0.021 0.017 DBMET00700 | DBMET00700 | |
| 0.037 | 0.098 | 0.103 | Thromboxane synthase inhibitor | 0.064 0.023 DBMET00698 0.1 0.006 DBMET00699 0.103 0.006 DBMET00700 0.051 0.045 DBMET00701 0.077 0.013 DBMET00702 | DBMET00700 | |
| 0.042 | 0.104 | 0.069 | Pregnane X receptor antagonist | 0.069 0.015 DBMET00637 0.064 0.023 DBMET00698 0.062 0.027 DBMET00699 0.064 0.023 DBMET00700 0.065 0.021 DBMET00701 0.063 0.024 DBMET00702 | DBMET00637 | |
| 0.088 | 0.151 | 0.342 | Protein kinase stimulant | 0.198 0.042 DBMET00637 0.191 0.045 DBMET00698 0.312 0.015 DBMET00699 0.326 0.014 DBMET00700 0.211 0.038 DBMET00701 0.342 0.012 DBMET00702 | DBMET00702 | |
| 0.018 | 0.081 | 0.027 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.027 0.019 DBMET00699 0.026 0.022 DBMET00700 | DBMET00699 | |
| 0.012 | 0.076 | 0.044 | Lysine carboxypeptidase inhibitor | 0.044 0.009 DBMET00699 0.039 0.011 DBMET00700 | DBMET00699 | |
| 0.092 | 0.157 | 0.291 | Diuretic | 0.24 0.032 DBMET00637 0.279 0.026 DBMET00699 0.291 0.024 DBMET00700 0.179 0.054 DBMET00702 | DBMET00700 | |
| 0.015 | 0.081 | 0.033 | Peptide deformylase inhibitor | 0.033 0.018 DBMET00637 0.03 0.021 DBMET00699 0.031 0.02 DBMET00700 | DBMET00637 | |
| 0.063 | 0.129 | 0.111 | ATPase (Vacuolar H+) inhibitor | 0.099 0.04 DBMET00637 0.087 0.061 DBMET00699 0.101 0.039 DBMET00700 0.098 0.043 DBMET00701 0.111 0.027 DBMET00702 | DBMET00702 | |
| 0.013 | 0.079 | 0.033 | HCV NS5B polymerase inhibitor | 0.033 0.02 DBMET00699 | DBMET00699 | |
| 0.016 | 0.083 | 0.038 | Calcitonin receptor agonist | 0.038 0.021 DBMET00699 0.034 0.023 DBMET00700 | DBMET00699 | |
| 0.116 | 0.183 | 0.186 | ATPase inhibitor | 0.184 0.053 DBMET00637 0.158 0.089 DBMET00698 0.178 0.06 DBMET00699 0.183 0.055 DBMET00700 0.166 0.077 DBMET00701 0.186 0.051 DBMET00702 | DBMET00702 | |
| 0.022 | 0.09 | 0.078 | Sphingosine 1-phosphate receptor 1 agonist | 0.078 0.006 DBMET00699 0.077 0.006 DBMET00700 0.058 0.014 DBMET00702 | DBMET00699 | |
| 0.084 | 0.152 | 0.166 | Interleukin 4 antagonist | 0.166 0.038 DBMET00637 0.149 0.05 DBMET00698 0.146 0.053 DBMET00699 0.157 0.044 DBMET00700 0.158 0.043 DBMET00701 0.155 0.045 DBMET00702 | DBMET00637 | |
| 0.016 | 0.084 | 0.072 | Retinoid X alpha receptor agonist | 0.032 0.028 DBMET00637 0.038 0.021 DBMET00698 0.067 0.01 DBMET00699 0.072 0.009 DBMET00700 0.038 0.021 DBMET00702 | DBMET00700 | |
| 0.005 | 0.073 | 0.019 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.016 0.005 DBMET00637 0.015 0.007 DBMET00699 0.019 0.004 DBMET00700 0.015 0.006 DBMET00702 | DBMET00700 | |
| 0.01 | 0.078 | 0.046 | Leukotriene B4 receptor 1 antagonist | 0.043 0.01 DBMET00699 0.046 0.008 DBMET00700 0.038 0.013 DBMET00702 | DBMET00700 | |
| 0.012 | 0.08 | 0.026 | Neuraminidase (Influenza B) inhibitor | 0.02 0.016 DBMET00637 0.026 0.007 DBMET00698 0.024 0.009 DBMET00699 0.023 0.011 DBMET00700 | DBMET00698 | |
| 0.023 | 0.092 | 0.046 | Retinoid X receptor antagonist | 0.036 0.031 DBMET00698 0.043 0.02 DBMET00699 0.046 0.016 DBMET00700 | DBMET00700 | |
| 0.015 | 0.083 | 0.116 | Free fatty acid receptor 1 antagonist | 0.036 0.02 DBMET00637 0.044 0.013 DBMET00698 0.116 0.003 DBMET00699 0.112 0.003 DBMET00700 0.035 0.022 DBMET00701 0.094 0.003 DBMET00702 | DBMET00699 | |
| 0.014 | 0.083 | 0.026 | Sodium/glucose cotransporter inhibitor | 0.026 0.018 DBMET00637 0.025 0.02 DBMET00698 | DBMET00637 | |
| 0.013 | 0.083 | 0.057 | Trypsin I inhibitor | 0.052 0.011 DBMET00699 0.057 0.01 DBMET00700 0.041 0.017 DBMET00702 | DBMET00700 | |
| 0.025 | 0.096 | 0.046 | Dihydrofolate reductase inhibitor | 0.046 0.025 DBMET00701 | DBMET00701 | |
| 0.012 | 0.083 | 0.022 | Retinoid X beta receptor antagonist | 0.02 0.016 DBMET00698 0.022 0.012 DBMET00699 0.022 0.01 DBMET00700 | DBMET00700 | |
| 0.113 | 0.185 | 0.449 | Lipocortins synthesis antagonist | 0.449 0.005 DBMET00637 0.205 0.053 DBMET00698 0.18 0.071 DBMET00699 0.185 0.067 DBMET00700 0.182 0.069 DBMET00701 0.161 0.091 DBMET00702 | DBMET00637 | |
| 0.036 | 0.108 | 0.058 | Botulinum neurotoxin type A inhibitor | 0.053 0.049 DBMET00699 0.058 0.041 DBMET00700 | DBMET00700 | |
| 0.033 | 0.106 | 0.143 | Glucose-6-phosphate translocase inhibitor | 0.143 0.004 DBMET00637 0.051 0.037 DBMET00698 0.067 0.017 DBMET00699 0.078 0.012 DBMET00700 0.071 0.015 DBMET00701 0.087 0.009 DBMET00702 | DBMET00637 | |
| 0.034 | 0.108 | 0.095 | Sphingosine kinase 2 inhibitor | 0.095 0.009 DBMET00637 0.055 0.039 DBMET00699 0.06 0.031 DBMET00700 | DBMET00637 | |
| 0.096 | 0.169 | 0.241 | Farnesoid X receptor antagonist | 0.178 0.03 DBMET00637 0.241 0.013 DBMET00698 0.189 0.025 DBMET00699 0.181 0.029 DBMET00700 0.199 0.022 DBMET00701 0.161 0.041 DBMET00702 | DBMET00698 | |
| 0.048 | 0.122 | 0.14 | CDC25A inhibitor | 0.079 0.044 DBMET00637 0.106 0.025 DBMET00699 0.14 0.014 DBMET00700 0.066 0.063 DBMET00701 0.109 0.023 DBMET00702 | DBMET00700 | |
| 0.038 | 0.113 | 0.089 | Sphingosine kinase inhibitor | 0.089 0.011 DBMET00637 0.06 0.04 DBMET00698 0.066 0.03 DBMET00699 0.072 0.022 DBMET00700 | DBMET00637 | |
| 0.003 | 0.078 | 0.029 | Prostaglandin EP4 agonist | 0.026 0.008 DBMET00698 0.029 0.007 DBMET00699 0.021 0.009 DBMET00700 | DBMET00699 | |
| 0.018 | 0.093 | 0.185 | Peroxisome proliferator-activated receptor alpha agonist | 0.152 0.006 DBMET00698 0.185 0.005 DBMET00699 0.185 0.005 DBMET00700 0.142 0.007 DBMET00701 0.17 0.005 DBMET00702 | DBMET00700 | |
| 0.007 | 0.082 | 0.023 | Angiotensin-converting enzyme 2 inhibitor | 0.023 0.007 DBMET00699 0.023 0.007 DBMET00700 0.016 0.015 DBMET00702 | DBMET00700 | |
| 0.02 | 0.096 | 0.039 | Retinoid X alpha receptor antagonist | 0.035 0.021 DBMET00699 0.039 0.016 DBMET00700 | DBMET00700 | |
| 0.011 | 0.087 | 0.026 | Isoleucine-tRNA ligase inhibitor | 0.024 0.012 DBMET00699 0.026 0.009 DBMET00700 0.023 0.015 DBMET00702 | DBMET00700 | |
| 0.068 | 0.144 | 0.166 | Proteasome inhibitor | 0.166 0.038 DBMET00637 0.115 0.07 DBMET00698 0.161 0.04 DBMET00699 0.162 0.04 DBMET00700 0.101 0.086 DBMET00701 0.147 0.048 DBMET00702 | DBMET00637 | |
| 0.004 | 0.081 | 0.051 | G-protein-coupled receptor 120 agonist | 0.017 0.011 DBMET00698 0.049 0.004 DBMET00699 0.051 0.004 DBMET00700 0.037 0.004 DBMET00702 | DBMET00700 | |
| 0.034 | 0.111 | 0.107 | Matrix metalloproteinase inhibitor | 0.103 0.025 DBMET00699 0.107 0.024 DBMET00700 0.098 0.027 DBMET00702 | DBMET00700 | |
| 0.064 | 0.141 | 0.172 | ABCA1 expression enhancer | 0.172 0.013 DBMET00698 0.098 0.053 DBMET00699 0.098 0.053 DBMET00700 0.139 0.02 DBMET00701 0.086 0.074 DBMET00702 | DBMET00698 | |
| 0.031 | 0.109 | 0.066 | Dopamine beta hydroxylase inhibitor | 0.066 0.01 DBMET00637 0.048 0.035 DBMET00698 0.055 0.022 DBMET00699 0.056 0.02 DBMET00700 | DBMET00637 | |
| 0.045 | 0.123 | 0.119 | Glutamate (mGluR7) antagonist | 0.075 0.034 DBMET00637 0.079 0.029 DBMET00698 0.119 0.005 DBMET00699 0.109 0.007 DBMET00700 0.071 0.041 DBMET00701 0.11 0.006 DBMET00702 | DBMET00699 | |
| 0.009 | 0.087 | 0.022 | 5-Alpha-reductase 2 inhibitor | 0.022 0.012 DBMET00699 0.02 0.013 DBMET00700 | DBMET00699 | |
| 0.063 | 0.141 | 0.129 | Thioredoxin inhibitor | 0.129 0.025 DBMET00637 0.105 0.043 DBMET00699 0.099 0.049 DBMET00700 0.099 0.049 DBMET00702 | DBMET00637 | |
| 0.125 | 0.206 | 0.458 | Cyclic AMP phosphodiesterase inhibitor | 0.458 0.01 DBMET00637 0.195 0.098 DBMET00698 0.165 0.129 DBMET00700 0.256 0.061 DBMET00701 0.191 0.101 DBMET00702 | DBMET00637 | |
| 0.005 | 0.085 | 0.146 | Neutral endopeptidase inhibitor | 0.145 0.004 DBMET00699 0.146 0.004 DBMET00700 0.072 0.005 DBMET00702 | DBMET00700 | |
| 0.01 | 0.091 | 0.027 | Dopamine D1 agonist | 0.027 0.011 DBMET00637 | DBMET00637 | |
| 0.009 | 0.09 | 0.036 | Uridine phosphorylase inhibitor | 0.036 0.014 DBMET00637 0.035 0.014 DBMET00699 0.034 0.015 DBMET00700 | DBMET00637 | |
| 0.03 | 0.111 | 0.073 | Matrix metalloproteinase (membrane-type) inhibitor | 0.07 0.024 DBMET00699 0.073 0.023 DBMET00700 0.067 0.027 DBMET00702 | DBMET00700 | |
| 0.024 | 0.106 | 0.096 | Alpha tubulin antagonist | 0.096 0.016 DBMET00637 0.072 0.023 DBMET00701 0.079 0.02 DBMET00702 | DBMET00637 | |
| 0.046 | 0.128 | 0.089 | Trypsin inhibitor | 0.083 0.025 DBMET00699 0.089 0.022 DBMET00700 0.07 0.033 DBMET00702 | DBMET00700 | |
| 0.02 | 0.103 | 0.06 | Membrane dipeptidase inhibitor | 0.048 0.017 DBMET00698 0.056 0.012 DBMET00699 0.06 0.01 DBMET00700 0.038 0.03 DBMET00702 | DBMET00700 | |
| 0.005 | 0.087 | 0.027 | Integrin alpha4beta7 antagonist | 0.027 0.01 DBMET00699 0.027 0.01 DBMET00700 0.023 0.013 DBMET00702 | DBMET00700 | |
| 0.04 | 0.124 | 0.154 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.154 0.018 DBMET00637 0.104 0.036 DBMET00698 0.13 0.025 DBMET00699 0.118 0.03 DBMET00700 0.102 0.037 DBMET00701 0.128 0.026 DBMET00702 | DBMET00637 | |
| 0.043 | 0.126 | 0.058 | Lipocortins synthesis agonist | 0.058 0.039 DBMET00637 0.055 0.047 DBMET00698 0.055 0.049 DBMET00699 0.057 0.043 DBMET00700 | DBMET00637 | |
| 0.015 | 0.098 | 0.029 | Lysophosphatidic acid 2 receptor antagonist | 0.029 0.023 DBMET00637 0.028 0.026 DBMET00701 | DBMET00637 | |
| 0.046 | 0.13 | 0.144 | Metalloproteinase-2 inhibitor | 0.072 0.062 DBMET00698 0.14 0.022 DBMET00699 0.144 0.02 DBMET00700 0.129 0.025 DBMET00702 | DBMET00700 | |
| 0.011 | 0.096 | 0.079 | Retinoid X receptor agonist | 0.079 0.008 DBMET00698 0.063 0.013 DBMET00699 0.068 0.011 DBMET00700 0.052 0.017 DBMET00701 0.034 0.026 DBMET00702 | DBMET00698 | |
| 0.013 | 0.098 | 0.026 | ICAM 1 antagonist | 0.026 0.01 DBMET00699 0.026 0.01 DBMET00700 | DBMET00700 | |
| 0.047 | 0.133 | 0.126 | Metalloproteinase-9 inhibitor | 0.121 0.025 DBMET00699 0.126 0.023 DBMET00700 0.117 0.026 DBMET00702 | DBMET00700 | |
| 0.027 | 0.114 | 0.058 | Neuraminidase inhibitor | 0.055 0.05 DBMET00698 0.058 0.045 DBMET00700 0.054 0.051 DBMET00701 | DBMET00700 | |
| 0.086 | 0.173 | 0.168 | Sphingosine 1-phosphate receptor 4 antagonist | 0.164 0.023 DBMET00637 0.127 0.06 DBMET00698 0.168 0.02 DBMET00699 0.157 0.028 DBMET00700 0.135 0.05 DBMET00702 | DBMET00699 | |
| 0.013 | 0.1 | 0.063 | Kainate receptor antagonist | 0.063 0.015 DBMET00699 0.056 0.018 DBMET00700 | DBMET00699 | |
| 0.037 | 0.125 | 0.098 | Na+ K+ transporting ATPase inhibitor | 0.09 0.041 DBMET00637 0.081 0.049 DBMET00698 0.095 0.036 DBMET00699 0.098 0.033 DBMET00700 0.081 0.049 DBMET00702 | DBMET00700 | |
| 0.074 | 0.162 | 0.178 | Photosensitizer | 0.154 0.029 DBMET00637 0.159 0.026 DBMET00698 0.178 0.018 DBMET00699 0.161 0.025 DBMET00700 0.138 0.039 DBMET00701 0.155 0.028 DBMET00702 | DBMET00699 | |
| 0.017 | 0.106 | 0.034 | Angiotensin II receptor antagonist | 0.034 0.024 DBMET00699 | DBMET00699 | |
| 0.172 | 0.261 | 0.406 | Calcium channel activator | 0.326 0.068 DBMET00637 0.383 0.031 DBMET00698 0.329 0.065 DBMET00699 0.305 0.086 DBMET00700 0.406 0.022 DBMET00701 0.352 0.048 DBMET00702 | DBMET00701 | |
| 0.01 | 0.1 | 0.021 | Caspase 8 inhibitor | 0.021 0.012 DBMET00699 0.02 0.013 DBMET00700 | DBMET00699 | |
| 0.005 | 0.095 | 0.053 | Estrogen receptor alpha agonist | 0.053 0.016 DBMET00637 0.039 0.021 DBMET00698 0.047 0.018 DBMET00699 | DBMET00637 | |
| 0.009 | 0.099 | 0.023 | Glutamate (mGluR1a) agonist | 0.023 0.014 DBMET00699 | DBMET00699 | |
| 0.006 | 0.099 | 0.039 | Prostaglandin EP2 agonist | 0.039 0.009 DBMET00698 0.029 0.013 DBMET00699 0.026 0.014 DBMET00700 | DBMET00698 | |
| 0.054 | 0.147 | 0.155 | Falcipain 3 inhibitor | 0.155 0.034 DBMET00637 0.094 0.077 DBMET00698 0.136 0.044 DBMET00699 0.145 0.039 DBMET00700 0.091 0.08 DBMET00701 0.133 0.045 DBMET00702 | DBMET00637 | |
| 0.065 | 0.158 | 0.14 | GABA C receptor antagonist | 0.14 0.036 DBMET00637 0.139 0.037 DBMET00698 0.138 0.038 DBMET00699 0.125 0.048 DBMET00700 | DBMET00637 | |
| 0.006 | 0.1 | 0.046 | Estrogen receptor beta agonist | 0.046 0.02 DBMET00637 0.039 0.021 DBMET00698 0.034 0.023 DBMET00699 | DBMET00637 | |
| 0.084 | 0.179 | 0.824 | Angiogenesis stimulant | 0.174 0.108 DBMET00637 0.824 0.004 DBMET00698 0.296 0.051 DBMET00699 0.311 0.045 DBMET00700 0.767 0.004 DBMET00701 0.292 0.052 DBMET00702 | DBMET00698 | |
| 0.02 | 0.115 | 0.075 | Matrix metalloproteinase 1 inhibitor | 0.072 0.025 DBMET00699 0.075 0.024 DBMET00700 0.07 0.026 DBMET00702 | DBMET00700 | |
| 0.137 | 0.233 | 0.331 | DNA synthesis inhibitor | 0.221 0.093 DBMET00637 0.331 0.035 DBMET00698 0.225 0.088 DBMET00699 0.221 0.093 DBMET00700 0.271 0.055 DBMET00701 0.184 0.148 DBMET00702 | DBMET00698 | |
| 0.028 | 0.124 | 0.108 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.087 0.014 DBMET00637 0.108 0.009 DBMET00698 0.08 0.016 DBMET00699 0.063 0.026 DBMET00700 0.06 0.03 DBMET00701 | DBMET00698 | |
| 0.036 | 0.132 | 0.106 | NMDA receptor agonist | 0.066 0.04 DBMET00698 0.106 0.017 DBMET00699 0.101 0.019 DBMET00700 | DBMET00699 | |
| 0.011 | 0.109 | 0.032 | Prostaglandin D2 agonist | 0.032 0.019 DBMET00698 0.031 0.021 DBMET00699 0.03 0.022 DBMET00700 | DBMET00698 | |
| 0.011 | 0.109 | 0.035 | Nicotinic acid receptor 2 antagonist | 0.025 0.021 DBMET00637 0.024 0.023 DBMET00698 0.035 0.008 DBMET00699 0.032 0.01 DBMET00700 | DBMET00699 | |
| 0.016 | 0.115 | 0.056 | Oxytocin agonist | 0.048 0.025 DBMET00637 0.056 0.02 DBMET00699 0.05 0.024 DBMET00700 | DBMET00699 | |
| 0.017 | 0.116 | 0.046 | Phosphorylase inhibitor | 0.046 0.033 DBMET00637 | DBMET00637 | |
| 0.164 | 0.263 | 0.453 | GABA C receptor rho-3 antagonist | 0.453 0.04 DBMET00637 0.388 0.067 DBMET00698 0.388 0.067 DBMET00699 0.317 0.105 DBMET00700 | DBMET00637 | |
| 0.004 | 0.104 | 0.093 | Free fatty acid receptor 1 agonist | 0.018 0.011 DBMET00698 0.091 0.004 DBMET00699 0.093 0.004 DBMET00700 0.048 0.005 DBMET00702 | DBMET00700 | |
| 0.052 | 0.152 | 0.137 | Estrogen receptor alpha antagonist | 0.137 0.014 DBMET00637 0.116 0.02 DBMET00698 0.106 0.024 DBMET00699 0.098 0.028 DBMET00700 0.085 0.041 DBMET00701 0.08 0.049 DBMET00702 | DBMET00637 | |
| 0.159 | 0.26 | 0.329 | DNA polymerase beta inhibitor | 0.329 0.15 DBMET00637 | DBMET00637 | |
| 0.017 | 0.118 | 0.042 | Angiotensin AT1 receptor antagonist | 0.042 0.029 DBMET00699 | DBMET00699 | |
| 0.023 | 0.124 | 0.043 | Calcium-independent phospholipase A2 inhibitor | 0.043 0.007 DBMET00637 0.034 0.025 DBMET00698 | DBMET00637 | |
| 0.028 | 0.129 | 0.059 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.059 0.036 DBMET00637 0.051 0.047 DBMET00700 | DBMET00637 | |
| 0.121 | 0.222 | 0.206 | Histone acetyltransferase inhibitor | 0.206 0.06 DBMET00637 | DBMET00637 | |
| 0.023 | 0.124 | 0.128 | Opioid delta receptor antagonist | 0.128 0.024 DBMET00699 0.084 0.035 DBMET00700 | DBMET00699 | |
| 0.035 | 0.137 | 0.076 | Prostaglandin F2 alpha antagonist | 0.074 0.028 DBMET00699 0.076 0.026 DBMET00700 | DBMET00700 | |
| 0.009 | 0.112 | 0.049 | Prostaglandin agonist | 0.037 0.015 DBMET00637 0.049 0.01 DBMET00698 0.048 0.011 DBMET00699 0.044 0.012 DBMET00700 0.028 0.025 DBMET00701 0.028 0.026 DBMET00702 | DBMET00698 | |
| 0.022 | 0.125 | 0.055 | Sphingosine kinase 1 inhibitor | 0.055 0.012 DBMET00637 0.043 0.026 DBMET00700 | DBMET00637 | |
| 0.01 | 0.113 | 0.121 | Peroxisome proliferator-activated receptor delta agonist | 0.096 0.006 DBMET00698 0.116 0.005 DBMET00699 0.121 0.005 DBMET00700 0.089 0.006 DBMET00701 0.107 0.005 DBMET00702 | DBMET00700 | |
| 0.02 | 0.124 | 0.094 | Sphingosine 1-phosphate receptor agonist | 0.094 0.006 DBMET00699 0.09 0.007 DBMET00700 0.066 0.013 DBMET00702 | DBMET00699 | |
| 0.032 | 0.136 | 0.062 | CD45 antagonist | 0.062 0.02 DBMET00698 0.052 0.032 DBMET00699 0.05 0.034 DBMET00700 0.047 0.042 DBMET00701 | DBMET00698 | |
| 0.029 | 0.133 | 0.083 | Sphingosine 1-phosphate receptor 3 antagonist | 0.075 0.021 DBMET00637 0.083 0.015 DBMET00699 0.074 0.022 DBMET00700 | DBMET00699 | |
| 0.007 | 0.113 | 0.029 | Sphingosine 1-phosphate receptor 3 agonist | 0.029 0.028 DBMET00700 | DBMET00700 | |
| 0.011 | 0.119 | 0.065 | Phosphoglycerate kinase inhibitor | 0.06 0.011 DBMET00637 0.049 0.014 DBMET00698 0.065 0.01 DBMET00701 0.031 0.029 DBMET00702 | DBMET00701 | |
| 0.065 | 0.173 | 0.189 | Microtubule formation inhibitor | 0.166 0.03 DBMET00637 0.151 0.037 DBMET00698 0.157 0.034 DBMET00699 0.173 0.028 DBMET00700 0.183 0.024 DBMET00701 0.189 0.023 DBMET00702 | DBMET00702 | |
| 0.058 | 0.167 | 0.155 | Estrogen receptor beta antagonist | 0.148 0.016 DBMET00637 0.155 0.014 DBMET00698 0.133 0.021 DBMET00699 0.111 0.045 DBMET00700 0.109 0.048 DBMET00701 0.096 0.072 DBMET00702 | DBMET00698 | |
| 0.005 | 0.114 | 0.029 | Prostaglandin E2 agonist | 0.021 0.019 DBMET00637 0.029 0.011 DBMET00698 0.029 0.011 DBMET00699 0.026 0.013 DBMET00700 | DBMET00699 | |
| 0.058 | 0.169 | 0.184 | Adenylate cyclase inhibitor | 0.151 0.044 DBMET00637 0.114 0.073 DBMET00698 0.164 0.037 DBMET00699 0.184 0.029 DBMET00700 0.123 0.065 DBMET00702 | DBMET00700 | |
| 0.071 | 0.184 | 0.172 | Estrogen antagonist | 0.152 0.022 DBMET00637 0.172 0.017 DBMET00698 0.168 0.018 DBMET00699 0.132 0.036 DBMET00700 0.12 0.054 DBMET00701 0.119 0.057 DBMET00702 | DBMET00698 | |
| 0.024 | 0.138 | 0.116 | Opioid mu receptor antagonist | 0.116 0.026 DBMET00699 0.078 0.041 DBMET00700 | DBMET00699 | |
| 0.003 | 0.118 | 0.108 | Peroxisome proliferator-activated receptor alpha antagonist | 0.105 0.004 DBMET00698 0.108 0.004 DBMET00699 0.103 0.004 DBMET00700 0.061 0.007 DBMET00701 0.064 0.007 DBMET00702 | DBMET00699 | |
| 0.013 | 0.127 | 0.039 | Glutamate (mGluR1) agonist | 0.023 0.022 DBMET00698 0.039 0.006 DBMET00699 0.033 0.008 DBMET00700 | DBMET00699 | |
| 0.008 | 0.123 | 0.029 | Leukotriene D4 antagonist | 0.029 0.016 DBMET00699 0.029 0.016 DBMET00700 | DBMET00700 | |
| 0.043 | 0.158 | 0.059 | Heme oxygenase stimulant | 0.059 0.048 DBMET00637 | DBMET00637 | |
| 0.044 | 0.16 | 0.157 | Opioid antagonist | 0.157 0.024 DBMET00699 0.116 0.038 DBMET00700 0.085 0.062 DBMET00702 | DBMET00699 | |
| 0.091 | 0.208 | 0.162 | Papain-like protease (SARS coronavirus) inhibitor | 0.138 0.047 DBMET00637 0.162 0.024 DBMET00698 0.125 0.069 DBMET00699 0.119 0.083 DBMET00700 0.151 0.033 DBMET00701 0.119 0.083 DBMET00702 | DBMET00698 | |
| 0.026 | 0.144 | 0.149 | Antineoplastic antibiotic | 0.149 0.031 DBMET00637 | DBMET00637 | |
| 0.019 | 0.138 | 0.039 | Tryptophan 5 hydroxylase inhibitor | 0.039 0.018 DBMET00637 0.037 0.023 DBMET00699 0.038 0.019 DBMET00700 | DBMET00637 | |
| 0.073 | 0.191 | 0.098 | Factor V inhibitor | 0.098 0.074 DBMET00698 | DBMET00698 | |
| 0.078 | 0.198 | 0.247 | Neurotrophic factor | 0.247 0.013 DBMET00637 0.161 0.05 DBMET00699 0.181 0.037 DBMET00700 0.114 0.106 DBMET00701 0.169 0.044 DBMET00702 | DBMET00637 | |
| 0.045 | 0.165 | 0.139 | Peroxisome proliferator-activated receptor gamma antagonist | 0.074 0.045 DBMET00637 0.139 0.007 DBMET00698 0.139 0.007 DBMET00699 0.134 0.008 DBMET00700 0.117 0.01 DBMET00701 0.117 0.01 DBMET00702 | DBMET00699 | |
| 0.085 | 0.207 | 0.171 | Thiol protease inhibitor | 0.171 0.054 DBMET00637 0.153 0.066 DBMET00699 0.158 0.062 DBMET00700 0.125 0.107 DBMET00702 | DBMET00637 | |
| 0.021 | 0.144 | 0.056 | AICAR transformylase inhibitor | 0.049 0.024 DBMET00698 0.056 0.017 DBMET00699 0.055 0.018 DBMET00700 | DBMET00699 | |
| 0.036 | 0.159 | 0.105 | Protease 3C (Human rhinovirus) inhibitor | 0.085 0.023 DBMET00637 0.077 0.03 DBMET00698 0.105 0.014 DBMET00699 0.095 0.018 DBMET00700 0.076 0.03 DBMET00702 | DBMET00699 | |
| 0.017 | 0.14 | 0.038 | Erythropoietin receptor agonist | 0.038 0.03 DBMET00699 | DBMET00699 | |
| 0.064 | 0.188 | 0.096 | Glutamate (mGluR7) agonist | 0.09 0.084 DBMET00701 0.096 0.068 DBMET00702 | DBMET00702 | |
| 0.01 | 0.134 | 0.079 | Estrogen agonist | 0.079 0.023 DBMET00637 0.066 0.028 DBMET00698 0.076 0.024 DBMET00699 | DBMET00637 | |
| 0.004 | 0.129 | 0.151 | Calcium-dependent phospholipase A2 inhibitor | 0.011 0.01 DBMET00637 0.144 0.003 DBMET00699 0.151 0.003 DBMET00700 0.048 0.003 DBMET00702 | DBMET00700 | |
| 0.032 | 0.157 | 0.071 | Elastase 1 inhibitor | 0.065 0.054 DBMET00637 0.065 0.054 DBMET00698 0.067 0.051 DBMET00699 0.071 0.045 DBMET00700 | DBMET00700 | |
| 0.085 | 0.211 | 0.173 | Amyloid beta precursor protein antagonist | 0.156 0.095 DBMET00699 0.167 0.083 DBMET00700 0.173 0.078 DBMET00702 | DBMET00702 | |
| 0.004 | 0.13 | 0.073 | Integrin alpha4 antagonist | 0.073 0.008 DBMET00699 0.065 0.009 DBMET00700 0.035 0.014 DBMET00702 | DBMET00699 | |
| 0.015 | 0.141 | 0.06 | Glycine transporter 2 inhibitor | 0.06 0.025 DBMET00698 0.056 0.027 DBMET00699 | DBMET00698 | |
| 0.085 | 0.211 | 0.174 | NOS3 expression enhancer | 0.154 0.068 DBMET00637 0.129 0.099 DBMET00698 0.165 0.059 DBMET00699 0.174 0.053 DBMET00700 0.14 0.084 DBMET00702 | DBMET00700 | |
| 0.032 | 0.158 | 0.086 | CDC25B inhibitor | 0.076 0.031 DBMET00637 0.075 0.032 DBMET00699 0.086 0.023 DBMET00700 0.069 0.039 DBMET00702 | DBMET00700 | |
| 0.022 | 0.149 | 0.062 | NMDA receptor glycine site agonist | 0.061 0.044 DBMET00698 0.062 0.044 DBMET00699 0.062 0.044 DBMET00700 | DBMET00700 | |
| 0.114 | 0.241 | 0.171 | Heat shock protein 70 antagonist | 0.155 0.036 DBMET00637 0.148 0.049 DBMET00698 0.168 0.019 DBMET00699 0.171 0.017 DBMET00700 0.15 0.044 DBMET00701 0.17 0.017 DBMET00702 | DBMET00700 | |
| 0.127 | 0.255 | 0.241 | Transcription factor STAT3 inhibitor | 0.229 0.102 DBMET00637 0.232 0.099 DBMET00698 0.225 0.106 DBMET00699 0.24 0.092 DBMET00700 0.241 0.09 DBMET00701 0.234 0.097 DBMET00702 | DBMET00701 | |
| 0.074 | 0.202 | 0.135 | Mcl-1 antagonist | 0.135 0.106 DBMET00700 | DBMET00700 | |
| 0.061 | 0.19 | 0.15 | Toll-Like receptor 4 antagonist | 0.107 0.058 DBMET00637 0.112 0.052 DBMET00698 0.15 0.021 DBMET00699 0.148 0.022 DBMET00700 0.117 0.046 DBMET00701 0.149 0.022 DBMET00702 | DBMET00699 | |
| 0.055 | 0.186 | 0.117 | GABA C receptor rho-1 antagonist | 0.117 0.043 DBMET00637 0.114 0.046 DBMET00698 0.114 0.046 DBMET00699 0.098 0.065 DBMET00700 | DBMET00637 | |
| 0.014 | 0.145 | 0.054 | NMDA 2A receptor antagonist | 0.054 0.034 DBMET00699 | DBMET00699 | |
| 0.009 | 0.141 | 0.07 | Kainate receptor 2 antagonist | 0.067 0.009 DBMET00699 0.07 0.009 DBMET00700 | DBMET00700 | |
| 0.033 | 0.166 | 0.059 | Heat shock protein 90 beta antagonist | 0.059 0.042 DBMET00637 | DBMET00637 | |
| 0.019 | 0.151 | 0.053 | AMPA 4 receptor antagonist | 0.053 0.013 DBMET00699 0.048 0.017 DBMET00700 | DBMET00699 | |
| 0.012 | 0.145 | 0.026 | Purinergic P2Y15 antagonist | 0.026 0.025 DBMET00637 | DBMET00637 | |
| 0.145 | 0.279 | 0.412 | DNA directed DNA polymerase inhibitor | 0.412 0.111 DBMET00637 | DBMET00637 | |
| 0.011 | 0.144 | 0.031 | Liver X receptor alpha antagonist | 0.031 0.017 DBMET00698 0.027 0.023 DBMET00701 | DBMET00698 | |
| 0.056 | 0.19 | 0.128 | Beta glucuronidase inhibitor | 0.128 0.038 DBMET00637 | DBMET00637 | |
| 0.006 | 0.141 | 0.124 | Squalene synthetase inhibitor | 0.046 0.016 DBMET00698 0.124 0.005 DBMET00699 0.123 0.005 DBMET00700 0.034 0.021 DBMET00701 0.098 0.006 DBMET00702 | DBMET00699 | |
| 0.018 | 0.153 | 0.077 | Liver X receptor alpha agonist | 0.043 0.026 DBMET00637 0.077 0.007 DBMET00698 0.057 0.014 DBMET00699 0.055 0.015 DBMET00700 0.064 0.01 DBMET00701 0.048 0.021 DBMET00702 | DBMET00698 | |
| 0.066 | 0.202 | 0.241 | TRPA1 agonist | 0.241 0.006 DBMET00637 0.195 0.012 DBMET00698 0.212 0.009 DBMET00699 0.19 0.013 DBMET00700 0.152 0.03 DBMET00701 0.165 0.022 DBMET00702 | DBMET00637 | |
| 0.009 | 0.145 | 0.055 | Liver X receptor beta antagonist | 0.051 0.008 DBMET00698 0.055 0.007 DBMET00699 0.046 0.01 DBMET00700 0.025 0.024 DBMET00701 0.029 0.02 DBMET00702 | DBMET00699 | |
| 0.006 | 0.143 | 0.023 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.023 0.015 DBMET00637 | DBMET00637 | |
| 0.009 | 0.146 | 0.087 | Prostaglandin EP4 antagonist | 0.027 0.017 DBMET00698 0.087 0.005 DBMET00699 0.082 0.005 DBMET00700 0.05 0.008 DBMET00702 | DBMET00699 | |
| 0.004 | 0.142 | 0.015 | KiSS-1 receptor antagonist | 0.015 0.014 DBMET00637 | DBMET00637 | |
| 0.027 | 0.166 | 0.065 | Squalene epoxidase inhibitor | 0.065 0.017 DBMET00637 0.052 0.031 DBMET00698 0.056 0.025 DBMET00699 0.061 0.02 DBMET00700 | DBMET00637 | |
| 0.012 | 0.151 | 0.069 | NMDA receptor subunit 3A antagonist | 0.034 0.031 DBMET00698 0.069 0.014 DBMET00699 0.04 0.025 DBMET00700 | DBMET00699 | |
| 0.043 | 0.184 | 0.15 | Protease inhibitor | 0.089 0.075 DBMET00637 0.15 0.03 DBMET00698 0.13 0.04 DBMET00699 0.128 0.042 DBMET00700 0.129 0.041 DBMET00701 0.112 0.055 DBMET00702 | DBMET00698 | |
| 0.016 | 0.157 | 0.043 | Adenosine deaminase inhibitor | 0.041 0.039 DBMET00637 0.043 0.037 DBMET00700 | DBMET00700 | |
| 0.015 | 0.158 | 0.075 | Endothelin-converting enzyme inhibitor | 0.075 0.019 DBMET00699 0.071 0.02 DBMET00700 0.048 0.031 DBMET00702 | DBMET00699 | |
| 0.008 | 0.153 | 0.036 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.035 0.025 DBMET00637 0.036 0.024 DBMET00699 | DBMET00699 | |
| 0.012 | 0.157 | 0.047 | Geranyltranstransferase inhibitor | 0.047 0.026 DBMET00637 0.046 0.027 DBMET00699 0.046 0.027 DBMET00700 | DBMET00637 | |
| 0.038 | 0.184 | 0.072 | Ryanodine receptor antagonist | 0.064 0.027 DBMET00637 0.06 0.038 DBMET00698 0.058 0.044 DBMET00699 0.06 0.039 DBMET00700 0.072 0.016 DBMET00701 0.069 0.019 DBMET00702 | DBMET00701 | |
| 0.008 | 0.155 | 0.027 | Lysophosphatidic acid 1 receptor antagonist | 0.025 0.009 DBMET00699 0.025 0.009 DBMET00700 0.027 0.008 DBMET00702 | DBMET00702 | |
| 0.125 | 0.273 | 0.242 | RNA-directed DNA polymerase inhibitor | 0.239 0.057 DBMET00637 0.239 0.057 DBMET00698 0.198 0.103 DBMET00699 0.217 0.077 DBMET00700 0.242 0.054 DBMET00701 0.2 0.099 DBMET00702 | DBMET00701 | |
| 0.014 | 0.164 | 0.057 | GABA uptake inhibitor | 0.036 0.032 DBMET00637 0.039 0.027 DBMET00698 0.057 0.011 DBMET00699 0.055 0.012 DBMET00700 | DBMET00699 | |
| 0.039 | 0.189 | 0.129 | Anesthetic local | 0.129 0.06 DBMET00637 0.103 0.08 DBMET00699 0.107 0.077 DBMET00700 0.1 0.082 DBMET00702 | DBMET00637 | |
| 0.009 | 0.16 | 0.107 | Urate transporter 1 inhibitor | 0.043 0.023 DBMET00698 0.107 0.005 DBMET00699 0.097 0.005 DBMET00700 0.075 0.009 DBMET00702 | DBMET00699 | |
| 0.008 | 0.16 | 0.016 | Antibiotic Tetracycline-like | 0.016 0.008 DBMET00637 | DBMET00637 | |
| 0.017 | 0.169 | 0.074 | NMDA receptor subunit 3B antagonist | 0.074 0.015 DBMET00699 0.049 0.026 DBMET00700 | DBMET00699 | |
| 0.03 | 0.185 | 0.061 | Factor III inhibitor | 0.053 0.027 DBMET00637 0.058 0.02 DBMET00699 0.058 0.019 DBMET00700 0.05 0.034 DBMET00701 0.061 0.017 DBMET00702 | DBMET00702 | |
| 0.023 | 0.179 | 0.055 | Glutamate (mGluR4) antagonist | 0.055 0.017 DBMET00699 0.053 0.018 DBMET00700 | DBMET00699 | |
| 0.024 | 0.18 | 0.043 | Integrin alpha1beta1 antagonist | 0.042 0.016 DBMET00699 0.043 0.015 DBMET00700 0.037 0.03 DBMET00702 | DBMET00700 | |
| 0.014 | 0.171 | 0.291 | Prostaglandin EP2 antagonist | 0.062 0.039 DBMET00698 0.284 0.005 DBMET00699 0.291 0.004 DBMET00700 0.052 0.05 DBMET00701 0.225 0.005 DBMET00702 | DBMET00700 | |
| 0.016 | 0.176 | 0.032 | Estrogen-related receptor beta antagonist | 0.031 0.026 DBMET00698 0.032 0.024 DBMET00699 | DBMET00699 | |
| 0.059 | 0.22 | 0.103 | Glutamate release inhibitor | 0.098 0.045 DBMET00637 0.103 0.038 DBMET00699 0.102 0.039 DBMET00700 0.096 0.049 DBMET00702 | DBMET00699 | |
| 0.053 | 0.215 | 0.167 | M17 leucyl aminopeptidase inhibitor | 0.154 0.053 DBMET00699 0.167 0.046 DBMET00700 0.156 0.052 DBMET00702 | DBMET00700 | |
| 0.03 | 0.193 | 0.148 | Calcium antagonist | 0.092 0.053 DBMET00637 0.107 0.043 DBMET00699 0.103 0.046 DBMET00700 0.089 0.056 DBMET00701 0.148 0.023 DBMET00702 | DBMET00702 | |
| 0.049 | 0.212 | 0.084 | MAP kinase kinase 7 inhibitor | 0.084 0.036 DBMET00637 0.084 0.036 DBMET00698 0.077 0.054 DBMET00699 | DBMET00698 | |
| 0.05 | 0.214 | 0.096 | Alkylator | 0.096 0.093 DBMET00702 | DBMET00702 | |
| 0.061 | 0.225 | 0.166 | NADPH oxidase inhibitor | 0.131 0.07 DBMET00637 0.109 0.098 DBMET00698 0.126 0.075 DBMET00699 0.131 0.07 DBMET00700 0.139 0.062 DBMET00701 0.166 0.046 DBMET00702 | DBMET00702 | |
| 0.025 | 0.19 | 0.066 | Heparanase inhibitor | 0.066 0.015 DBMET00637 0.063 0.018 DBMET00699 0.061 0.021 DBMET00700 0.061 0.022 DBMET00702 | DBMET00637 | |
| 0.025 | 0.194 | 0.041 | CF transmembrane conductance regulator antagonist | 0.041 0.024 DBMET00637 | DBMET00637 | |
| 0.038 | 0.209 | 0.075 | Exportin-1 inhibitor | 0.075 0.033 DBMET00637 0.073 0.036 DBMET00699 0.072 0.04 DBMET00700 0.066 0.054 DBMET00702 | DBMET00637 | |
| 0.013 | 0.184 | 0.103 | Macrophage elastase inhibitor | 0.094 0.01 DBMET00699 0.103 0.009 DBMET00700 0.071 0.014 DBMET00702 | DBMET00700 | |
| 0.04 | 0.212 | 0.067 | Transcription factor RelA inhibitor | 0.065 0.041 DBMET00637 0.067 0.036 DBMET00701 | DBMET00701 | |
| 0.077 | 0.25 | 0.27 | Interleukin antagonist | 0.207 0.08 DBMET00637 0.167 0.106 DBMET00698 0.27 0.055 DBMET00699 0.243 0.064 DBMET00700 0.21 0.079 DBMET00702 | DBMET00699 | |
| 0.05 | 0.223 | 0.092 | Electrolyte absorption antagonist | 0.089 0.075 DBMET00637 0.087 0.08 DBMET00698 0.09 0.074 DBMET00699 0.092 0.07 DBMET00700 | DBMET00700 | |
| 0.003 | 0.178 | 0.032 | Kainate receptor 1 antagonist | 0.032 0.009 DBMET00699 0.029 0.011 DBMET00700 | DBMET00699 | |
| 0.122 | 0.297 | 0.212 | Neuropeptide Y2 antagonist | 0.195 0.128 DBMET00637 0.181 0.158 DBMET00698 0.212 0.1 DBMET00699 0.181 0.157 DBMET00700 | DBMET00699 | |
| 0.003 | 0.179 | 0.038 | Integrin alpha4beta1 antagonist | 0.038 0.006 DBMET00699 0.026 0.008 DBMET00700 0.021 0.009 DBMET00702 | DBMET00699 | |
| 0.01 | 0.186 | 0.158 | Beta tubulin antagonist | 0.119 0.018 DBMET00637 0.058 0.041 DBMET00699 0.086 0.027 DBMET00700 0.103 0.021 DBMET00701 0.158 0.011 DBMET00702 | DBMET00702 | |
| 0.078 | 0.256 | 0.173 | GABA C receptor rho-2 antagonist | 0.173 0.048 DBMET00637 0.158 0.064 DBMET00698 0.158 0.064 DBMET00699 0.132 0.101 DBMET00700 0.126 0.112 DBMET00701 0.126 0.112 DBMET00702 | DBMET00637 | |
| 0.062 | 0.239 | 0.113 | Folate antagonist | 0.113 0.045 DBMET00698 0.101 0.063 DBMET00701 | DBMET00698 | |
| 0.034 | 0.212 | 0.094 | Glycine receptor antagonist | 0.08 0.057 DBMET00637 0.094 0.038 DBMET00698 0.076 0.063 DBMET00699 0.076 0.064 DBMET00700 | DBMET00698 | |
| 0.018 | 0.198 | 0.046 | Diacylglycerol O-acyltransferase inhibitor | 0.046 0.042 DBMET00699 | DBMET00699 | |
| 0.032 | 0.213 | 0.321 | Protein-tyrosine phosphatase 1B inhibitor | 0.118 0.065 DBMET00637 0.321 0.009 DBMET00698 0.188 0.033 DBMET00699 0.205 0.028 DBMET00700 0.272 0.013 DBMET00701 0.165 0.04 DBMET00702 | DBMET00698 | |
| 0.059 | 0.241 | 0.351 | Amyloid beta aggregation inhibitor | 0.351 0.034 DBMET00637 0.165 0.098 DBMET00699 0.233 0.063 DBMET00700 0.198 0.079 DBMET00701 0.313 0.043 DBMET00702 | DBMET00637 | |
| 0.007 | 0.189 | 0.049 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.049 0.012 DBMET00637 0.029 0.026 DBMET00699 | DBMET00637 | |
| 0.017 | 0.199 | 0.055 | Neuraminidase (Influenza A) inhibitor | 0.055 0.018 DBMET00698 0.051 0.022 DBMET00701 | DBMET00698 | |
| 0.038 | 0.221 | 0.122 | Mediator release inhibitor | 0.122 0.046 DBMET00637 0.11 0.059 DBMET00699 0.109 0.06 DBMET00700 0.104 0.065 DBMET00702 | DBMET00637 | |
| 0.05 | 0.233 | 0.224 | Bone formation stimulant | 0.176 0.043 DBMET00698 0.224 0.03 DBMET00699 0.205 0.034 DBMET00700 0.152 0.057 DBMET00701 0.18 0.042 DBMET00702 | DBMET00699 | |
| 0.038 | 0.222 | 0.132 | Sphingomyelinase inhibitor | 0.117 0.043 DBMET00637 0.112 0.047 DBMET00699 0.111 0.049 DBMET00700 0.095 0.065 DBMET00701 0.132 0.033 DBMET00702 | DBMET00702 | |
| 0.049 | 0.235 | 0.084 | Transcription factor NF kappa B stimulant | 0.084 0.061 DBMET00637 0.078 0.075 DBMET00700 | DBMET00637 | |
| 0.009 | 0.196 | 0.06 | Nicotinic acid receptor agonist | 0.04 0.021 DBMET00637 0.06 0.011 DBMET00699 0.041 0.02 DBMET00700 | DBMET00699 | |
| 0.035 | 0.222 | 0.067 | Caspase 9 inhibitor | 0.067 0.036 DBMET00699 0.065 0.039 DBMET00700 | DBMET00699 | |
| 0.09 | 0.279 | 0.255 | Calpain inhibitor | 0.246 0.068 DBMET00637 0.255 0.06 DBMET00699 0.251 0.064 DBMET00700 0.224 0.09 DBMET00702 | DBMET00699 | |
| 0.009 | 0.2 | 0.03 | Liver X receptor antagonist | 0.03 0.023 DBMET00698 0.028 0.026 DBMET00699 | DBMET00698 | |
| 0.008 | 0.2 | 0.062 | Estradiol 17 beta-dehydrogenase inhibitor | 0.062 0.019 DBMET00637 0.049 0.025 DBMET00699 0.041 0.03 DBMET00700 0.036 0.035 DBMET00702 | DBMET00637 | |
| 0.025 | 0.221 | 0.068 | Transcription factor AP-1 inhibitor | 0.068 0.033 DBMET00637 0.062 0.041 DBMET00700 0.064 0.038 DBMET00702 | DBMET00637 | |
| 0.075 | 0.271 | 0.109 | DNA repair enzyme inhibitor | 0.109 0.1 DBMET00637 | DBMET00637 | |
| 0.039 | 0.236 | 0.126 | Antineoplastic alkaloid | 0.112 0.041 DBMET00698 0.126 0.035 DBMET00701 0.076 0.071 DBMET00702 | DBMET00701 | |
| 0.011 | 0.21 | 0.05 | Fructose-1,6-bisphosphatase inhibitor | 0.05 0.024 DBMET00699 0.048 0.027 DBMET00700 0.047 0.029 DBMET00702 | DBMET00699 | |
| 0.02 | 0.22 | 0.074 | Androgen agonist | 0.067 0.033 DBMET00637 0.074 0.027 DBMET00698 0.066 0.034 DBMET00699 0.062 0.039 DBMET00700 | DBMET00698 | |
| 0.027 | 0.228 | 0.055 | Heme oxygenase inhibitor | 0.055 0.009 DBMET00637 | DBMET00637 | |
| 0.06 | 0.263 | 0.184 | Interleukin 8 antagonist | 0.147 0.036 DBMET00637 0.141 0.04 DBMET00698 0.183 0.018 DBMET00699 0.184 0.018 DBMET00700 0.113 0.071 DBMET00701 0.15 0.034 DBMET00702 | DBMET00700 | |
| 0.005 | 0.209 | 0.031 | Kynurenine 3 monooxygenase inhibitor | 0.03 0.016 DBMET00699 0.031 0.015 DBMET00700 0.03 0.016 DBMET00702 | DBMET00700 | |
| 0.009 | 0.213 | 0.043 | Opioid mu receptor agonist | 0.043 0.037 DBMET00637 0.042 0.038 DBMET00699 | DBMET00637 | |
| 0.007 | 0.213 | 0.076 | Integrin antagonist | 0.076 0.02 DBMET00699 0.07 0.022 DBMET00700 | DBMET00699 | |
| 0.025 | 0.233 | 0.127 | NMDA receptor antagonist | 0.127 0.032 DBMET00699 0.092 0.052 DBMET00700 | DBMET00699 | |
| 0.027 | 0.236 | 0.154 | Analgesic, opioid | 0.083 0.044 DBMET00637 0.154 0.014 DBMET00699 0.118 0.023 DBMET00700 0.083 0.044 DBMET00702 | DBMET00699 | |
| 0.043 | 0.252 | 0.134 | Cyclooxygenase 1 inhibitor | 0.128 0.073 DBMET00699 0.133 0.068 DBMET00700 0.134 0.068 DBMET00702 | DBMET00702 | |
| 0.017 | 0.226 | 0.062 | Adenylate cyclase 1 inhibitor | 0.062 0.017 DBMET00637 0.044 0.035 DBMET00698 0.052 0.024 DBMET00699 0.048 0.029 DBMET00700 | DBMET00637 | |
| 0.009 | 0.219 | 0.058 | Guanylate cyclase inhibitor | 0.058 0.013 DBMET00637 0.041 0.032 DBMET00699 0.039 0.035 DBMET00700 | DBMET00637 | |
| 0.029 | 0.239 | 0.087 | Topoisomerase I inhibitor | 0.087 0.083 DBMET00637 | DBMET00637 | |
| 0.007 | 0.218 | 0.034 | HMG CoA reductase inhibitor | 0.034 0.025 DBMET00698 0.032 0.029 DBMET00699 0.032 0.029 DBMET00700 | DBMET00698 | |
| 0.039 | 0.251 | 0.272 | Tubulin antagonist | 0.183 0.043 DBMET00637 0.121 0.079 DBMET00700 0.2 0.037 DBMET00701 0.272 0.023 DBMET00702 | DBMET00702 | |
| 0.079 | 0.293 | 0.191 | CF transmembrane conductance regulator agonist | 0.165 0.053 DBMET00637 0.191 0.027 DBMET00698 0.145 0.086 DBMET00699 0.167 0.051 DBMET00701 | DBMET00698 | |
| 0.014 | 0.231 | 0.028 | Hedgehog signaling activator | 0.027 0.019 DBMET00637 0.027 0.02 DBMET00699 0.027 0.019 DBMET00700 0.028 0.018 DBMET00702 | DBMET00702 | |
| 0.052 | 0.268 | 0.41 | Electron transport complex I inhibitor | 0.41 0.004 DBMET00637 0.116 0.052 DBMET00698 0.104 0.074 DBMET00699 0.113 0.057 DBMET00700 0.159 0.017 DBMET00701 0.148 0.021 DBMET00702 | DBMET00637 | |
| 0.023 | 0.243 | 0.056 | CXC chemokine 1 receptor antagonist | 0.049 0.039 DBMET00637 0.056 0.027 DBMET00699 0.055 0.029 DBMET00700 | DBMET00699 | |
| 0.007 | 0.232 | 0.042 | Glutamate (mGluR group II) antagonist | 0.041 0.023 DBMET00699 0.042 0.022 DBMET00700 | DBMET00700 | |
| 0.004 | 0.23 | 0.027 | Endothelin A receptor antagonist | 0.027 0.011 DBMET00699 0.026 0.011 DBMET00700 0.027 0.011 DBMET00702 | DBMET00702 | |
| 0.007 | 0.235 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.021 0.013 DBMET00637 | DBMET00637 | |
| 0.05 | 0.279 | 0.185 | Aryl hydrocarbon receptor agonist | 0.185 0.111 DBMET00637 | DBMET00637 | |
| 0.039 | 0.271 | 0.132 | AMP-activated protein kinase stimulant | 0.09 0.085 DBMET00637 0.132 0.04 DBMET00698 0.129 0.042 DBMET00701 | DBMET00698 | |
| 0.04 | 0.276 | 0.077 | Calcium channel P-type blocker | 0.066 0.037 DBMET00637 0.062 0.051 DBMET00698 0.077 0.017 DBMET00701 0.067 0.034 DBMET00702 | DBMET00701 | |
| 0.094 | 0.331 | 0.207 | Catenin beta inhibitor | 0.207 0.027 DBMET00698 0.169 0.069 DBMET00699 0.143 0.123 DBMET00700 0.175 0.058 DBMET00701 0.14 0.13 DBMET00702 | DBMET00698 | |
| 0.019 | 0.259 | 0.052 | Human rhinovirus A protease inhibitor | 0.052 0.041 DBMET00637 | DBMET00637 | |
| 0.029 | 0.271 | 0.076 | Somatostatin 1 agonist | 0.076 0.056 DBMET00699 | DBMET00699 | |
| 0.004 | 0.247 | 0.115 | Prostaglandin EP3 antagonist | 0.109 0.005 DBMET00699 0.115 0.005 DBMET00700 0.061 0.008 DBMET00702 | DBMET00700 | |
| 0.016 | 0.26 | 0.094 | Purinergic P2X2 antagonist | 0.061 0.051 DBMET00699 0.094 0.033 DBMET00702 | DBMET00702 | |
| 0.013 | 0.257 | 0.045 | Dihydroorotase inhibitor | 0.045 0.03 DBMET00637 | DBMET00637 | |
| 0.004 | 0.25 | 0.025 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.025 0.014 DBMET00699 0.025 0.014 DBMET00700 0.022 0.018 DBMET00702 | DBMET00700 | |
| 0.107 | 0.353 | 0.256 | Transcription factor inhibitor | 0.256 0.183 DBMET00637 | DBMET00637 | |
| 0.009 | 0.255 | 0.035 | Alpha 1d adrenoreceptor agonist | 0.035 0.032 DBMET00637 | DBMET00637 | |
| 0.034 | 0.282 | 0.117 | Opioid kappa receptor antagonist | 0.117 0.025 DBMET00699 0.093 0.043 DBMET00700 0.074 0.069 DBMET00702 | DBMET00699 | |
| 0.04 | 0.288 | 0.15 | Caspase 3 inhibitor | 0.12 0.059 DBMET00637 0.106 0.082 DBMET00698 0.15 0.028 DBMET00699 0.15 0.028 DBMET00700 0.134 0.042 DBMET00702 | DBMET00700 | |
| 0.069 | 0.318 | 0.394 | Non-steroidal antiinflammatory agent | 0.216 0.059 DBMET00637 0.265 0.037 DBMET00698 0.328 0.023 DBMET00699 0.348 0.02 DBMET00700 0.323 0.024 DBMET00701 0.394 0.014 DBMET00702 | DBMET00702 | |
| 0.043 | 0.292 | 0.121 | Nav1.4 sodium channel blocker | 0.121 0.051 DBMET00699 0.105 0.069 DBMET00700 | DBMET00699 | |
| 0.01 | 0.26 | 0.058 | Metalloproteinase-3 inhibitor | 0.058 0.025 DBMET00699 0.055 0.028 DBMET00700 0.056 0.027 DBMET00702 | DBMET00699 | |
| 0.007 | 0.258 | 0.049 | Liver X receptor beta agonist | 0.049 0.011 DBMET00698 0.03 0.029 DBMET00699 0.031 0.026 DBMET00701 | DBMET00698 | |
| 0.01 | 0.261 | 0.049 | Collagenase inhibitor | 0.049 0.035 DBMET00699 0.049 0.034 DBMET00700 | DBMET00700 | |
| 0.032 | 0.286 | 0.077 | Immunoglobulin Fc receptor antagonist | 0.059 0.026 DBMET00637 0.077 0.007 DBMET00699 0.07 0.011 DBMET00700 0.061 0.022 DBMET00702 | DBMET00699 | |
| 0.009 | 0.263 | 0.085 | NMDA 2C receptor antagonist | 0.085 0.022 DBMET00699 0.065 0.038 DBMET00700 | DBMET00699 | |
| 0.036 | 0.29 | 0.097 | Acetylcholine muscarinic antagonist | 0.097 0.094 DBMET00698 | DBMET00698 | |
| 0.049 | 0.308 | 0.138 | Acetylcholine M1 receptor antagonist | 0.138 0.087 DBMET00637 0.123 0.104 DBMET00698 | DBMET00637 | |
| 0.008 | 0.268 | 0.031 | Cholesterol ester transfer protein antagonist | 0.031 0.022 DBMET00637 0.028 0.027 DBMET00700 | DBMET00637 | |
| 0.051 | 0.319 | 0.095 | CC chemokine 5 receptor agonist | 0.09 0.036 DBMET00637 0.08 0.064 DBMET00698 0.095 0.028 DBMET00699 0.083 0.054 DBMET00700 | DBMET00699 | |
| 0.026 | 0.295 | 0.073 | Interferon inducer | 0.073 0.031 DBMET00698 0.063 0.047 DBMET00699 0.062 0.049 DBMET00700 | DBMET00698 | |
| 0.018 | 0.289 | 0.161 | Androgen antagonist | 0.155 0.021 DBMET00637 0.161 0.02 DBMET00698 0.117 0.035 DBMET00701 | DBMET00698 | |
| 0.055 | 0.33 | 0.546 | Hypolipemic | 0.201 0.093 DBMET00637 0.546 0.009 DBMET00698 0.437 0.019 DBMET00699 0.441 0.019 DBMET00700 0.468 0.015 DBMET00701 0.369 0.031 DBMET00702 | DBMET00698 | |
| 0.014 | 0.293 | 0.058 | Collagenase 3 inhibitor | 0.058 0.044 DBMET00699 0.058 0.044 DBMET00700 0.055 0.048 DBMET00702 | DBMET00700 | |
| 0.007 | 0.288 | 0.029 | LFA antagonist | 0.028 0.019 DBMET00699 0.029 0.018 DBMET00700 | DBMET00700 | |
| 0.032 | 0.318 | 0.145 | Interleukin 1 beta converting enzyme inhibitor | 0.125 0.031 DBMET00637 0.145 0.019 DBMET00699 0.138 0.023 DBMET00700 0.115 0.04 DBMET00702 | DBMET00699 | |
| 0.035 | 0.324 | 0.084 | Vanilloid 4 agonist | 0.069 0.068 DBMET00637 0.084 0.034 DBMET00699 0.083 0.035 DBMET00700 | DBMET00699 | |
| 0.049 | 0.339 | 0.116 | Interleukin 12 antagonist | 0.116 0.032 DBMET00698 0.095 0.062 DBMET00699 0.099 0.055 DBMET00701 | DBMET00698 | |
| 0.082 | 0.372 | 0.164 | Death-associated protein kinase 2 inhibitor | 0.164 0.077 DBMET00637 | DBMET00637 | |
| 0.023 | 0.319 | 0.09 | Interferon agonist | 0.09 0.038 DBMET00698 0.077 0.056 DBMET00699 0.077 0.057 DBMET00700 | DBMET00698 | |
| 0.003 | 0.3 | 0.038 | Prostaglandin EP1 antagonist | 0.038 0.008 DBMET00699 0.036 0.009 DBMET00700 0.019 0.014 DBMET00702 | DBMET00699 | |
| 0.058 | 0.358 | 0.229 | Prostaglandin dehydrogenase inhibitor | 0.229 0.139 DBMET00637 | DBMET00637 | |
| 0.014 | 0.315 | 0.043 | Cholesterol esterase inhibitor | 0.043 0.042 DBMET00700 | DBMET00700 | |
| 0.059 | 0.362 | 0.133 | Hemostatic | 0.121 0.113 DBMET00699 0.133 0.091 DBMET00700 | DBMET00700 | |
| 0.011 | 0.316 | 0.054 | Prolyl endopeptidase inhibitor | 0.054 0.031 DBMET00637 | DBMET00637 | |
| 0.052 | 0.358 | 0.428 | Platelet antagonist | 0.277 0.061 DBMET00698 0.406 0.026 DBMET00699 0.428 0.022 DBMET00700 0.235 0.079 DBMET00701 0.353 0.037 DBMET00702 | DBMET00700 | |
| 0.053 | 0.361 | 0.311 | Antiamyloidogenic | 0.166 0.127 DBMET00637 0.203 0.098 DBMET00699 0.236 0.077 DBMET00700 0.159 0.136 DBMET00701 0.311 0.048 DBMET00702 | DBMET00702 | |
| 0.061 | 0.371 | 0.154 | 3C-like protease (Human coronavirus) inhibitor | 0.154 0.095 DBMET00637 0.139 0.123 DBMET00699 | DBMET00637 | |
| 0.061 | 0.373 | 0.134 | Pregnane X receptor agonist | 0.134 0.088 DBMET00637 0.13 0.099 DBMET00698 0.13 0.101 DBMET00699 0.13 0.101 DBMET00700 | DBMET00637 | |
| 0.052 | 0.364 | 0.219 | Hexokinase inhibitor | 0.219 0.026 DBMET00637 0.173 0.055 DBMET00698 0.158 0.07 DBMET00699 0.14 0.09 DBMET00700 0.136 0.096 DBMET00701 0.12 0.119 DBMET00702 | DBMET00637 | |
| 0.077 | 0.39 | 0.209 | Transcription factor STAT inhibitor | 0.208 0.127 DBMET00637 0.207 0.128 DBMET00698 0.204 0.133 DBMET00699 0.209 0.125 DBMET00700 0.191 0.151 DBMET00701 0.187 0.157 DBMET00702 | DBMET00700 | |
| 0.037 | 0.353 | 0.129 | Lanosterol 14 alpha demethylase inhibitor | 0.129 0.022 DBMET00637 0.119 0.031 DBMET00698 0.109 0.043 DBMET00699 0.096 0.062 DBMET00700 | DBMET00637 | |
| 0.028 | 0.353 | 0.081 | Chymotrypsin inhibitor | 0.081 0.053 DBMET00637 0.074 0.064 DBMET00699 | DBMET00637 | |
| 0.051 | 0.376 | 0.203 | P-glycoprotein inhibitor | 0.155 0.11 DBMET00637 0.138 0.137 DBMET00698 0.148 0.12 DBMET00699 0.152 0.114 DBMET00700 0.193 0.069 DBMET00701 0.203 0.062 DBMET00702 | DBMET00702 | |
| 0.022 | 0.35 | 0.076 | Histamine N-methyltransferase inhibitor | 0.076 0.071 DBMET00637 | DBMET00637 | |
| 0.016 | 0.347 | 0.044 | Vanilloid 3 antagonist | 0.037 0.029 DBMET00701 0.044 0.015 DBMET00702 | DBMET00702 | |
| 0.034 | 0.374 | 0.15 | Cyclooxygenase inhibitor | 0.142 0.076 DBMET00699 0.15 0.07 DBMET00700 0.146 0.074 DBMET00702 | DBMET00700 | |
| 0.016 | 0.362 | 0.05 | Guanylate cyclase stimulant | 0.05 0.021 DBMET00699 0.048 0.023 DBMET00700 | DBMET00699 | |
| 0.006 | 0.354 | 0.063 | Aromatase inhibitor | 0.063 0.04 DBMET00637 | DBMET00637 | |
| 0.004 | 0.353 | 0.041 | Farnesoid X receptor agonist | 0.041 0.023 DBMET00698 | DBMET00698 | |
| 0.009 | 0.365 | 0.144 | Prostaglandin-E synthase inhibitor | 0.078 0.041 DBMET00698 0.138 0.014 DBMET00699 0.144 0.013 DBMET00700 0.095 0.029 DBMET00702 | DBMET00700 | |
| 0.007 | 0.363 | 0.102 | Leukocyte elastase inhibitor | 0.102 0.009 DBMET00699 0.1 0.01 DBMET00700 0.085 0.012 DBMET00702 | DBMET00699 | |
| 0.014 | 0.375 | 0.079 | Epoxide hydrolase inhibitor | 0.079 0.043 DBMET00699 0.079 0.043 DBMET00700 | DBMET00700 | |
| 0.038 | 0.402 | 0.11 | Phosphodiesterase 6D inhibitor | 0.11 0.036 DBMET00637 0.089 0.078 DBMET00698 0.099 0.054 DBMET00699 0.104 0.045 DBMET00700 0.092 0.069 DBMET00702 | DBMET00637 | |
| 0.007 | 0.372 | 0.135 | Prostaglandin antagonist | 0.131 0.012 DBMET00699 0.135 0.012 DBMET00700 0.077 0.024 DBMET00702 | DBMET00700 | |
| 0.037 | 0.403 | 0.234 | Cell adhesion inhibitor | 0.098 0.094 DBMET00698 0.229 0.018 DBMET00699 0.234 0.017 DBMET00700 0.103 0.085 DBMET00701 0.216 0.021 DBMET00702 | DBMET00700 | |
| 0.008 | 0.379 | 0.044 | Liver X receptor agonist | 0.044 0.03 DBMET00698 | DBMET00698 | |
| 0.016 | 0.388 | 0.07 | Potassium channel (ATP-sensitive) blocker | 0.07 0.041 DBMET00698 0.067 0.045 DBMET00701 | DBMET00698 | |
| 0.01 | 0.384 | 0.02 | Vitamin D receptor antagonist | 0.02 0.019 DBMET00698 | DBMET00698 | |
| 0.012 | 0.388 | 0.082 | HIV-1 reverse transcriptase inhibitor | 0.082 0.041 DBMET00637 | DBMET00637 | |
| 0.014 | 0.396 | 0.1 | CYP2A6 inhibitor | 0.1 0.036 DBMET00637 | DBMET00637 | |
| 0.034 | 0.42 | 0.142 | Acetylcholine release stimulant | 0.142 0.022 DBMET00637 | DBMET00637 | |
| 0.004 | 0.396 | 0.046 | Leukotriene A4 hydrolase inhibitor | 0.046 0.022 DBMET00699 0.042 0.024 DBMET00700 | DBMET00699 | |
| 0.035 | 0.427 | 0.137 | Heat shock protein 90 alpha antagonist | 0.137 0.102 DBMET00637 | DBMET00637 | |
| 0.031 | 0.424 | 0.199 | Anticoagulant | 0.182 0.06 DBMET00699 0.199 0.053 DBMET00700 0.142 0.087 DBMET00702 | DBMET00700 | |
| 0.05 | 0.452 | 0.211 | Tumour necrosis factor antagonist | 0.133 0.123 DBMET00700 0.188 0.061 DBMET00701 0.211 0.047 DBMET00702 | DBMET00702 | |
| 0.084 | 0.489 | 0.383 | Caspase 3 stimulant | 0.383 0.049 DBMET00637 0.202 0.166 DBMET00698 0.196 0.175 DBMET00700 0.307 0.075 DBMET00701 0.282 0.089 DBMET00702 | DBMET00637 | |
| 0.024 | 0.43 | 0.126 | Cytidine deaminase inhibitor | 0.126 0.095 DBMET00637 | DBMET00637 | |
| 0.012 | 0.42 | 0.035 | Adenosine uptake inhibitor | 0.035 0.022 DBMET00637 | DBMET00637 | |
| 0.022 | 0.429 | 0.104 | Cyclooxygenase 2 inhibitor | 0.104 0.099 DBMET00700 0.104 0.099 DBMET00702 | DBMET00702 | |
| 0.007 | 0.415 | 0.071 | TRPA1 antagonist | 0.071 0.032 DBMET00637 | DBMET00637 | |
| 0.043 | 0.453 | 0.359 | Insulin secretagoues | 0.295 0.013 DBMET00698 0.336 0.009 DBMET00699 0.359 0.008 DBMET00700 0.248 0.02 DBMET00701 0.286 0.014 DBMET00702 | DBMET00700 | |
| 0.104 | 0.516 | 0.188 | 5 Hydroxytryptamine 3E antagonist | 0.188 0.086 DBMET00637 | DBMET00637 | |
| 0.007 | 0.419 | 0.019 | Potassium channel (Inward rectifier) 11 blocker | 0.019 0.012 DBMET00698 | DBMET00698 | |
| 0.025 | 0.439 | 0.11 | Breast cancer-resistant protein inhibitor | 0.11 0.047 DBMET00701 0.109 0.048 DBMET00702 | DBMET00701 | |
| 0.038 | 0.474 | 0.078 | 3C-Like protease (SARS coronavirus) inhibitor | 0.078 0.076 DBMET00700 | DBMET00700 | |
| 0.005 | 0.445 | 0.045 | Glucocorticoid antagonist | 0.045 0.017 DBMET00698 0.035 0.021 DBMET00701 | DBMET00698 | |
| 0.064 | 0.505 | 0.249 | Toll-Like receptor 7 agonist | 0.218 0.18 DBMET00698 0.245 0.152 DBMET00699 0.248 0.149 DBMET00700 0.225 0.172 DBMET00701 0.249 0.148 DBMET00702 | DBMET00702 | |
| 0.045 | 0.486 | 0.31 | Calpain 2 inhibitor | 0.278 0.129 DBMET00637 0.31 0.108 DBMET00699 0.257 0.144 DBMET00700 0.198 0.19 DBMET00702 | DBMET00699 | |
| 0.037 | 0.48 | 0.092 | Ca(v)3.1 blocker | 0.092 0.033 DBMET00699 0.084 0.05 DBMET00700 0.082 0.055 DBMET00702 | DBMET00699 | |
| 0.037 | 0.482 | 0.108 | Histone deacetylase SIRT1 inhibitor | 0.108 0.107 DBMET00699 | DBMET00699 | |
| 0.062 | 0.509 | 0.247 | Toll-Like receptor agonist | 0.214 0.185 DBMET00698 0.242 0.156 DBMET00699 0.245 0.153 DBMET00700 0.223 0.175 DBMET00701 0.247 0.151 DBMET00702 | DBMET00702 | |
| 0.04 | 0.488 | 0.108 | Transcription factor STAT6 inhibitor | 0.108 0.085 DBMET00637 | DBMET00637 | |
| 0.025 | 0.473 | 0.122 | Beta amyloid protein antagonist | 0.101 0.088 DBMET00700 0.122 0.066 DBMET00702 | DBMET00702 | |
| 0.018 | 0.468 | 0.144 | Cell adhesion molecule inhibitor | 0.144 0.017 DBMET00699 0.135 0.019 DBMET00700 0.126 0.022 DBMET00702 | DBMET00699 | |
| 0.005 | 0.462 | 0.044 | AMPA receptor agonist | 0.044 0.013 DBMET00637 | DBMET00637 | |
| 0.037 | 0.501 | 0.221 | 5 Hydroxytryptamine 1E antagonist | 0.221 0.107 DBMET00637 | DBMET00637 | |
| 0.025 | 0.49 | 0.238 | Antibacterial (Helicobacter pylori) | 0.238 0.014 DBMET00637 0.13 0.067 DBMET00699 0.136 0.059 DBMET00700 0.14 0.055 DBMET00702 | DBMET00637 | |
| 0.007 | 0.473 | 0.064 | Amidase inhibitor | 0.064 0.058 DBMET00637 | DBMET00637 | |
| 0.005 | 0.473 | 0.036 | Histone deacetylase 7 inhibitor | 0.036 0.026 DBMET00637 | DBMET00637 | |
| 0.119 | 0.595 | 0.322 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.322 0.185 DBMET00637 | DBMET00637 | |
| 0.029 | 0.505 | 0.133 | Cytokine production inhibitor | 0.133 0.077 DBMET00637 | DBMET00637 | |
| 0.006 | 0.526 | 0.038 | Histone deacetylase 9 inhibitor | 0.038 0.029 DBMET00637 | DBMET00637 | |
| 0.063 | 0.59 | 0.583 | Apoptosis agonist | 0.57 0.056 DBMET00637 0.519 0.069 DBMET00698 0.245 0.22 DBMET00699 0.294 0.177 DBMET00700 0.583 0.053 DBMET00701 0.378 0.125 DBMET00702 | DBMET00701 | |
| 0.007 | 0.535 | 0.124 | Mineralocorticoid receptor antagonist | 0.124 0.005 DBMET00698 0.098 0.008 DBMET00701 | DBMET00698 | |
| 0.026 | 0.556 | 0.081 | Interleukin 5 antagonist | 0.081 0.071 DBMET00699 | DBMET00699 | |
| 0.026 | 0.562 | 0.188 | Interleukin 1 antagonist | 0.188 0.038 DBMET00637 0.118 0.091 DBMET00702 | DBMET00637 | |
| 0.012 | 0.56 | 0.078 | Caspase 7 inhibitor | 0.078 0.065 DBMET00637 | DBMET00637 | |
| 0.017 | 0.566 | 0.048 | Parathyroid hormone antagonist | 0.048 0.025 DBMET00698 0.044 0.036 DBMET00701 | DBMET00698 | |
| 0.005 | 0.568 | 0.115 | Prostaglandin E2 antagonist | 0.115 0.012 DBMET00699 0.115 0.012 DBMET00700 0.067 0.025 DBMET00702 | DBMET00700 | |
| 0.021 | 0.627 | 0.164 | Interleukin 6 antagonist | 0.152 0.086 DBMET00699 0.164 0.071 DBMET00700 0.162 0.073 DBMET00702 | DBMET00700 | |
| 0.023 | 0.631 | 0.162 | Interleukin 1b antagonist | 0.162 0.032 DBMET00637 0.111 0.07 DBMET00702 | DBMET00637 | |
| 0.013 | 0.662 | 0.122 | Multidrug resistance-associated protein 1 inhibitor | 0.094 0.09 DBMET00699 0.096 0.086 DBMET00700 0.122 0.046 DBMET00702 | DBMET00702 | |
| 0.006 | 0.657 | 0.093 | CC chemokine 5 receptor antagonist | 0.093 0.009 DBMET00698 0.061 0.025 DBMET00701 | DBMET00698 | |
| 0.022 | 0.7 | 0.421 | Antiobesity | 0.421 0.058 DBMET00698 0.214 0.193 DBMET00699 0.219 0.188 DBMET00700 0.279 0.132 DBMET00701 | DBMET00698 | |
| 0.004 | 0.714 | 0.053 | Acetyl-CoA transferase inhibitor | 0.053 0.037 DBMET00637 | DBMET00637 | |
| 0.01 | 0.734 | 0.215 | Antimitotic | 0.164 0.109 DBMET00701 0.215 0.076 DBMET00702 | DBMET00702 | |
| 0.034 | 0.759 | 0.224 | Growth factor agonist | 0.224 0.044 DBMET00637 | DBMET00637 | |
| 0.026 | 0.789 | 0.524 | Antiinflammatory | 0.524 0.078 DBMET00637 0.373 0.156 DBMET00698 0.374 0.156 DBMET00699 0.445 0.113 DBMET00700 0.382 0.15 DBMET00701 0.383 0.149 DBMET00702 | DBMET00637 | |
| 0.005 | 0.774 | 0.06 | Elastase inhibitor | 0.059 0.031 DBMET00699 0.06 0.03 DBMET00700 0.048 0.045 DBMET00702 | DBMET00700 | |
| 0.009 | 0.835 | 0.327 | Viral attachment inhibitor | 0.327 0.004 DBMET00698 0.26 0.004 DBMET00701 | DBMET00698 | |
| 0.007 | 0.838 | 0.276 | Platelet aggregation inhibitor | 0.176 0.101 DBMET00698 0.276 0.042 DBMET00701 0.22 0.068 DBMET00702 | DBMET00701 | |
| 0.007 | 0.856 | 0.275 | Tumour necrosis factor alpha release inhibitor | 0.236 0.082 DBMET00637 0.162 0.143 DBMET00700 0.18 0.126 DBMET00701 0.275 0.063 DBMET00702 | DBMET00702 | |
| 0.009 | 0.875 | 0.221 | Analgesic | 0.221 0.213 DBMET00699 | DBMET00699 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |